nct_id,title,sponsor,phase,completion_date,condition,ticker,market_cap,current_price,pct_change_30d,days_to_catalyst
NCT03029403,"Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer","University Health Network, Toronto",Phase 2,2025-12-12,"Advanced Cancer, Ovarian Cancer, Primary Peritoneal Carcinoma","(None, 0)",,,0.0,-1
NCT06066528,A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight,Boehringer Ingelheim,Phase 3,2025-12-12,"Obesity, Diabetes Mellitus, Type 2","(None, 0)",,,0.0,-1
NCT04452461,Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery,Hamilton Health Sciences Corporation,Phase 2,2025-12-12,Pancreatic Adenocarcinoma,"(None, 0)",,,0.0,-1
NCT07163624,UBT251 Injection Phase II (Type 2 Diabetes Mellitus) Study,"The United Bio-Technology (Hengqin) Co., Ltd.",Phase 2,2025-12-12,Type 2 Diabetes Mellitus (T2DM),"(None, 0)",,,0.0,-1
NCT03480776,ASA in Prevention of Ovarian Cancer (STICs and STONEs),Canadian Cancer Trials Group,Phase 2,2025-12-15,Ovarian Cancer Prevention,"(None, 0)",,,0.0,2
NCT07064720,Adding Dexmedetomidine to Mannitol to Attenuate the Increase of Intracranial Pressure,Cairo University,Phase 3,2025-12-15,Dexmedetomidine,"(None, 0)",,,0.0,2
NCT04348747,Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer,Roswell Park Cancer Institute,Phase 2,2025-12-15,"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Malignant Neoplasm in the Brain, Metastatic Triple-Negative Breast Carcinoma","(None, 0)",,,0.0,2
NCT03466294,Azacitidine and Venetoclax as Induction Therapy With Venetoclax Maintenance in the Elderly With AML,"University of Colorado, Denver",Phase 2,2025-12-15,Acute Myeloid Leukemia,"(None, 0)",,,0.0,2
NCT04010448,"A Trial to Assess the Safety, Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India",PATH,Phase 3,2025-12-15,Rotavirus Infection of Children,"(None, 0)",,,0.0,2
NCT06493019,"Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer",Dustin Deming,Phase 2,2025-12-15,Anal Cancer,"(None, 0)",,,0.0,2
NCT06006013,"Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer",Emory University,Phase 2,2025-12-16,"Locally Advanced Adrenal Cortex Carcinoma, Adrenal Cortical Carcinoma, Stage III Adrenal Cortex Carcinoma","(None, 0)",,,0.0,3
NCT04572815,Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant,Fred Hutchinson Cancer Center,Phase 2,2025-12-16,"Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid System Neoplasm","(None, 0)",,,0.0,3
NCT06508216,"A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer","Gustave Roussy, Cancer Campus, Grand Paris",Phase 2,2025-12-17,Breast Cancer,"(None, 0)",,,0.0,4
NCT05599191,A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough,Bellus Health Inc. - a GSK company,Phase 3,2025-12-18,"Cough, Refractory Chronic Cough","(None, 0)",,,0.0,5
NCT06503094,CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Phase 2,2025-12-18,B-Cell Lymphoblastic Leukemia/Lymphoma,"(None, 0)",,,0.0,5
NCT05731726,Serplulimab Combined with CAPEOX + Celecoxib As Neoadjuvant Treatment for Locally Advanced Rectal Cancer,Zhejiang University,Phase 2,2025-12-20,"PMMR, MSS, MSI-L","(None, 0)",,,0.0,7
NCT06861010,Evaluating the Safety and Efficacy of Ondansetron in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis,Tanta University,Phase 3,2025-12-20,Pancreatic Diseases,"(None, 0)",,,0.0,7
NCT04905901,Nebulized Tranexamic Acid in Sinus Surgery,Assiut University,Phase 3,2025-12-20,Bleeding Nose,"(None, 0)",,,0.0,7
NCT06530290,Evaluating the Effect of Mirtazapine on Anxiety in Parkinson's Disease Patients,Leila Dargahi. PharmD PhD,Phase 2,2025-12-20,"Parkinson Disease, Anxiety","(None, 0)",,,0.0,7
NCT06254274,A Study of RAY1225 in Participants With Type 2 Diabetes,"Guangdong Raynovent Biotech Co., Ltd",Phase 2,2025-12-20,T2DM (Type 2 Diabetes Mellitus),"(None, 0)",,,0.0,7
NCT06176885,Efficacy and Safety of Combined With Immunotherapy After Induction Therapy With Chemotherapy and Targeted Therapy in the First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer,yue junhan,Phase 2,2025-12-20,Colorectal Cancer,"(None, 0)",,,0.0,7
NCT04644016,Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders,Memorial Sloan Kettering Cancer Center,Phase 2,2025-12-20,"AML, ALL, MDS","(None, 0)",,,0.0,7
NCT05668013,A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease,Teva Branded Pharmaceutical Products R&D LLC,Phase 2,2025-12-20,"Crohn Disease, Colitis, Ulcerative","(None, 0)",,,0.0,7
NCT06444620,B/F/TAF to DTG/3TC Switch Study,University of Nairobi,Phase 3,2025-12-22,HIV-1-infection,"(None, 0)",,,0.0,9
NCT05960110,"Randomized Clinical Trial: Oral Health Package Law and Fluor Varnish Impact on Schoolchildren in Merida, Mexico",Anahuac Mayab University,Phase 3,2025-12-22,"Caries, Gum Disease","(None, 0)",,,0.0,9
NCT05824871,A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients,"Shanghai Jiatan Pharmatech Co., Ltd",Phase 3,2025-12-22,"Rifampin-Resistant Pulmonary Tuberculosis, Tuberculosis, Multidrug-Resistant (MDR-TB)","(None, 0)",,,0.0,9
NCT05908409,A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies,IDP Discovery Pharma S.L.,Phase 2,2025-12-22,"Multiple Myeloma (MM), Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Double Hit Lymphoma","(None, 0)",,,0.0,9
NCT05162742,Colchicine and Inflammation in Aortic Stenosis,Radboud University Medical Center,Phase 3,2025-12-22,"Aortic Valve Disease, Aortic Valve Stenosis, Aortic Valve Calcification","(None, 0)",,,0.0,9
NCT03996265,Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors,University of Rochester NCORP Research Base,Phase 3,2025-12-23,"Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm","('RHHBY', 100)",,,0.0,10
NCT05147558,A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma,Memorial Sloan Kettering Cancer Center,Phase 2,2025-12-23,"Uterine Carcinosarcoma, Advanced Uterine Carcinosarcoma","(None, 0)",,,0.0,10
NCT03707808,"Intratumoral Injection of Autologous CD1c (BDCA-1)+ MyDC, Avelumab, and Ipilimumab Plus Systemic Nivolumab",Universitair Ziekenhuis Brussel,Phase 2,2025-12-24,"Solid Tumor, Metastases to Soft Tissue","(None, 0)",,,0.0,11
NCT07154277,Small Bites Vs Large Bites Abdominal Midline Incisional Closure,Dow University of Health Sciences,Phase 3,2025-12-24,"Suture Techniques, Wound Closure Techniques, Laparotomy/Standerds","(None, 0)",,,0.0,11
NCT05179733,The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years,Ruijin Hospital,Phase 3,2025-12-25,Diffuse Large B-Cell Lymphoma,"(None, 0)",,,0.0,12
NCT05020535,Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH),Johns Hopkins University,Phase 2,2025-12-25,Intracerebral Hemorrhage,"(None, 0)",,,0.0,12
NCT01371630,Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia,M.D. Anderson Cancer Center,Phase 2,2025-12-25,"B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Burkitt-Like Lymphoma With 11q Aberration","(None, 0)",,,0.0,12
NCT05484349,TIzanidine for the Preventive Treatment of Episodic MigrainE （TIME）,"Second Affiliated Hospital, School of Medicine, Zhejiang University",Phase 3,2025-12-25,"Migraine Without Aura, Migraine With Aura","(None, 0)",,,0.0,12
NCT05578326,Study of Trilaciclib and Lurbinectidin,UNC Lineberger Comprehensive Cancer Center,Phase 2,2025-12-25,"Lung Cancer, Small-cell Lung Cancer","(None, 0)",,,0.0,12
NCT07263841,Comparison of Effectiveness of Tranexamic Acid Mesotherapy Versus Glutathione Mesotherapy in Post Burn Facial Hyperpigmentation,King Edward Medical University,Phase 2,2025-12-26,Post Burn Facial Hyperpigmentation,"(None, 0)",,,0.0,13
NCT05027386,"Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma: A Single-arm, Phase I/II，Multi-center, Clinical Study.",Sun Yat-sen University,Phase 2,2025-12-26,Neuroblastoma,"(None, 0)",,,0.0,13
NCT04302324,"A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab",Weill Medical College of Cornell University,Phase 2,2025-12-28,"Multiple Myeloma, Refractory Multiple Myeloma, Relapse Multiple Myeloma","(None, 0)",,,0.0,15
NCT05746039,Feasibility of Semaglutide in Advanced Lung Disease,University of Pennsylvania,Phase 2,2025-12-28,"Obesity, Interstitial Lung Disease, Chronic Obstructive Pulmonary Disease","(None, 0)",,,0.0,15
NCT05650645,The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial,University of Minnesota,Phase 2,2025-12-29,Tinnitus,"(None, 0)",,,0.0,16
NCT05035836,A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC),M.D. Anderson Cancer Center,Phase 2,2025-12-29,"Breast Cancer, HER2-positive","(None, 0)",,,0.0,16
NCT06891040,Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis,"Jiangsu vcare pharmaceutical technology co., LTD",Phase 2,2025-12-30,Atopic Dermatitis,"(None, 0)",,,0.0,17
NCT04304040,A Study of MIL62 Combined With Orelabrutinib for the Treatment of R/R CD20+B Cell Lymphoma,"Beijing InnoCare Pharma Tech Co., Ltd.",Phase 2,2025-12-30,"B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory","(None, 0)",,,0.0,17
NCT03611868,A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors,Ascentage Pharma Group Inc.,Phase 2,2025-12-30,"Unresectable or Metastatic Melanoma or Advanced Solid Tumors, Melanoma, Uveal Melanoma","(None, 0)",,,0.0,17
NCT04150744,RFA Plus Carrizumab vs Carrizumab Alone for HCC,"Second Affiliated Hospital, School of Medicine, Zhejiang University",Phase 2,2025-12-30,"Tumor Immunity, Immunosuppression, Radiofrequency Ablation","(None, 0)",,,0.0,17
NCT06594146,Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP),Keymed Biosciences Co.Ltd,Phase 2,2025-12-30,Primary Immune Thrombocytopenia,"(None, 0)",,,0.0,17
NCT05823987,Oncolytic Virotherapy Combined With Tislelizumab Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer (OPTIONS-05),Fudan University,Phase 2,2025-12-30,Advanced Biliary Tract Cancer,"(None, 0)",,,0.0,17
NCT03683225,A Study to Evaluate in Patients With Parkinsonian Type Disorders,Chase Therapeutics Corporation,Phase 2,2025-12-30,Idiopathic Parkinson Disease,"(None, 0)",,,0.0,17
NCT05835245,Cryoablation Combined With Sintilimab Plus Lenvatinib in 1L Treatment of Advanced ICC (CASTLE-ICC-Chemo-free),Fudan University,Phase 2,2025-12-30,Advanced Intrahepatic Cholangiocarcinoma,"(None, 0)",,,0.0,17
NCT06296082,Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity,Universiteit Antwerpen,Phase 3,2025-12-30,Stroke,"(None, 0)",,,0.0,17
NCT06704009,NT-101 Topical Ophthalmic Solution in Patients With Wet AMD,"NexThera Co., Ltd.",Phase 2,2025-12-30,"Wet Age Related Macular Degeneration, Wet AMD","(None, 0)",,,0.0,17
NCT04430699,Cisplatin+Pembrolizumab+RT in Vulvar Cancer,Massachusetts General Hospital,Phase 2,2025-12-30,"Vulvar Cancer, Vulvar Squamous Cell Carcinoma","(None, 0)",,,0.0,17
NCT06840704,Immunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer,Hunan Cancer Hospital,Phase 3,2025-12-30,"Non Small Cell Lung Cancer, Small Cell Lung Cancer","(None, 0)",,,0.0,17
NCT03885245,Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes,"University of Colorado, Denver",Phase 2,2025-12-30,"Asthma, Obesity","(None, 0)",,,0.0,17
NCT03641456,VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma,Sun Yat-sen University,Phase 2,2025-12-30,"Myeloma, Newly Diagnosed, High Risk","(None, 0)",,,0.0,17
NCT03463252,Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC,West China Second University Hospital,Phase 3,2025-12-30,"Endometrial Cancer, Atypical Endometrial Hyperplasia","(None, 0)",,,0.0,17
NCT04603014,Interdialytic Peritoneal UltraFiltration in HemoDialysis Patients,London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's,Phase 2,2025-12-30,"End Stage Renal Disease on Dialysis, Hemodialysis, Peritoneal Dialysis","(None, 0)",,,0.0,17
NCT04589754,Adriamycin and Ifosfamide Combined With Sintilimab,Sun Yat-sen University,Phase 2,2025-12-30,Soft Tissue Sarcoma,"(None, 0)",,,0.0,17
NCT06972511,Maximal Tumor Eradication for Oligometastatic Prostate Cancer,RenJi Hospital,Phase 3,2025-12-30,Oligometastatic Prostate Cancer,"(None, 0)",,,0.0,17
NCT06590324,A Study of Apabetalone in Subjects With Long -COVID,Resverlogix Corp,Phase 3,2025-12-30,Post-Acute COVID-19 Syndrome,"(None, 0)",,,0.0,17
NCT05374915,Efficacy and Safety Study of REM-001 Photodynamic Therapy for Treatment of Cutaneous Metastatic Breast Cancer (CMBC),"Kintara Therapeutics, Inc.",Phase 2,2025-12-30,Cutaneous Breast Cancer,"('NTLA', 86)",,,0.0,17
NCT06784648,"Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma",BioInvent International AB,Phase 2,2025-12-30,"Melanoma Metastatic, Melanoma of Skin, Melanoma BRAF V600E/K Mutated","(None, 0)",,,0.0,17
NCT06366698,Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia,Arrowhead Regional Medical Center,Phase 3,2025-12-30,Iron Deficiency Anemia of Pregnancy,"(None, 0)",,,0.0,17
NCT06394661,Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer,Henan Cancer Hospital,Phase 2,2025-12-30,Breast Cancer,"(None, 0)",,,0.0,17
NCT04214067,"Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer",National Cancer Institute (NCI),Phase 3,2025-12-30,"Endometrial Endometrioid Adenocarcinoma, Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8, Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8","(None, 0)",,,0.0,17
NCT05781074,Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer （CASTLE-08）,Fudan University,Phase 2,2025-12-30,Advanced Biliary Tract Cancer,"(None, 0)",,,0.0,17
NCT06211790,Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma,Fudan University,Phase 2,2025-12-30,"Kidney Cancer, Renal Cell Carcinoma, Renal Clear Cell Carcinoma","(None, 0)",,,0.0,17
NCT01917877,Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab,Qingdao Central Hospital,Phase 2,2025-12-30,Pulmonary Fibrosis,"(None, 0)",,,0.0,17
NCT04386317,Terazosin Effect on Cardiac Changes in Early Parkinson's Disease,Cedars-Sinai Medical Center,Phase 2,2025-12-30,"REM Sleep Behavior Disorder, Pre-motor Parkinson's Disease, Symptomatic Parkinson Disease","(None, 0)",,,0.0,17
NCT05930210,A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer,"Energenesis Biomedical Co., Ltd.",Phase 3,2025-12-30,"Diabetic Foot Ulcer, Foot Ulcer, Diabetes Mellitus","(None, 0)",,,0.0,17
NCT05455034,Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis,Xinqiao Hospital of Chongqing,Phase 2,2025-12-30,Pneumonitis,"(None, 0)",,,0.0,17
NCT05431413,Rapid Improvement of Depression of Fluoxetine Combined With ATP,"Nanfang Hospital, Southern Medical University",Phase 2,2025-12-30,Depression,"(None, 0)",,,0.0,17
NCT02313194,Spinal Cord Neuromodulation for Spinal Cord Injury,"University of California, Los Angeles",Phase 2,2025-12-30,"Cervical Spinal Cord Injury, Tetraparesis, Tetraplegia","(None, 0)",,,0.0,17
NCT06441565,Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer,Sun Yat-sen University,Phase 3,2025-12-30,Colorectal Cancer,"(None, 0)",,,0.0,17
NCT06209294,Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery,Xiaohua Wu,Phase 2,2025-12-30,"Neoadjuvant Immunotherapy, Cervical Cancer, Fertility-sparing Surgery","(None, 0)",,,0.0,17
NCT03419481,Pembrolizumab in Hepatocellular Carcinoma,CCTU,Phase 2,2025-12-30,HCC,"(None, 0)",,,0.0,17
NCT04438213,Ertugliflozin in Chronic Heart Failure,Yale University,Phase 2,2025-12-30,Heart Failure,"(None, 0)",,,0.0,17
NCT05241106,A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML),Tarapeutics Science Inc.,Phase 2,2025-12-30,Relapsed or Refractory Acute Myeloid Leukemia (AML),"('SLGN', 81)",,,0.0,17
NCT06032845,Cryoablation Combined with Tislelizumab Plus Lenvatinib in Previously Treated Solid Tumors (CASTLE-11),Fudan University,Phase 2,2025-12-30,"Solid Tumor, Adult","(None, 0)",,,0.0,17
NCT04588922,Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies,Sellas Life Sciences Group,Phase 2,2025-12-30,Hematologic Malignancies,"(None, 0)",,,0.0,17
NCT06123754,Phase III Study of Envafolimab Versus Placebo Plus Chemotherapy in Resectable Stage III NSCLC,"3D Medicines (Sichuan) Co., Ltd.",Phase 3,2025-12-30,Non-small Cell Lung Cancer,"(None, 0)",,,0.0,17
NCT05897268,Cryoablation Combined With Tislelizumab Plus Lenvatinib in 1L Treatment of Advanced HCC (CASTLE-10),Fudan University,Phase 2,2025-12-30,Hepatocellular Carcinoma,"(None, 0)",,,0.0,17
NCT07250542,A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer,baotai Liang,Phase 2,2025-12-30,Prostate Cancer,"(None, 0)",,,0.0,17
NCT06096090,Phase II Clinical Trial of Interleukin-2 in AD,The Methodist Hospital Research Institute,Phase 2,2025-12-30,Alzheimer Disease,"(None, 0)",,,0.0,17
NCT05672524,A Study of Tucatinib and Trastuzumab in People With Rectal Cancer,Memorial Sloan Kettering Cancer Center,Phase 2,2025-12-30,"Adenocarcinoma of the Rectum, Locally Advanced Rectal Adenocarcinoma, Rectal Adenocarcinoma","(None, 0)",,,0.0,17
NCT05929612,A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma,M.D. Anderson Cancer Center,Phase 2,2025-12-31,Lymphoma,"(None, 0)",,,0.0,18
NCT05662397,A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody,"HotSpot Therapeutics, Inc",Phase 2,2025-12-31,"Solid Tumor, Adult, Relapsed Cancer, Refractory Cancer","('CORT', 83)",,,0.0,18
NCT05661578,"A Study to Evaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Participants With Locally Advanced, Recurrent or Metastatic Solid Tumors",Hoffmann-La Roche,Phase 2,2025-12-31,PD-L1-selected Solid Tumors,"('RHHBY', 100)",,,0.0,18
NCT04616183,LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer,M.D. Anderson Cancer Center,Phase 2,2025-12-31,"Metastatic Colon Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma","(None, 0)",,,0.0,18
NCT05696353,Teen Driving Translation Study (NIH),Ginger Yang,Phase 3,2025-12-31,"Drive, Recidivism, Communication","(None, 0)",,,0.0,18
NCT03323346,Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer,"The Institute of Molecular and Translational Medicine, Czech Republic",Phase 2,2025-12-31,"Breast Neoplasm Female, Metastatic Breast Cancer","(None, 0)",,,0.0,18
NCT06626737,Dapagliflozin in Allo-HCT for aGVHD,The First Affiliated Hospital of Soochow University,Phase 2,2025-12-31,Graft-versus-host Disease (GVHD),"(None, 0)",,,0.0,18
NCT05704166,PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients,Fujian Medical University Union Hospital,Phase 2,2025-12-31,"Acute Lung Injury, Prevention","(None, 0)",,,0.0,18
NCT02935361,Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed,University of Southern California,Phase 2,2025-12-31,"Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes","(None, 0)",,,0.0,18
NCT05180097,Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma,Canadian Cancer Trials Group,Phase 2,2025-12-31,Hodgkin Lymphoma,"(None, 0)",,,0.0,18
NCT05438368,GD2/CD70 Bi-specific CAR-T Cell Therapy,Shenzhen Geno-Immune Medical Institute,Phase 2,2025-12-31,Cancer Disease,"(None, 0)",,,0.0,18
NCT05536128,Evaluating the Efficacy and Safety of Fulvestrant Plus DNA Damage Repair Inhibitors After a CDK4/6 Inhibitor,Seoul National University Hospital,Phase 2,2025-12-31,Advanced Breast Cancer,"(None, 0)",,,0.0,18
NCT04257461,A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma,Belgian Group of Digestive Oncology,Phase 3,2025-12-31,Small Bowel Adenocarcinoma,"(None, 0)",,,0.0,18
NCT05104983,Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study,Darcy Krueger,Phase 2,2025-12-31,"Tuberous Sclerosis Complex, Epilepsy","(None, 0)",,,0.0,18
NCT05356013,Caplyta in Borderline Personality Disorder,University of Chicago,Phase 2,2025-12-31,Borderline Personality Disorder,"(None, 0)",,,0.0,18
NCT06004856,Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia,"Beijing InnoCare Pharma Tech Co., Ltd.",Phase 3,2025-12-31,Chronic Primary Immune Thrombocytopenia (ITP),"(None, 0)",,,0.0,18
NCT04331041,Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma,Washington University School of Medicine,Phase 2,2025-12-31,"Pancreas Cancer, Cancer of the Pancreas, Pancreas Adenocarcinoma","(None, 0)",,,0.0,18
NCT00488072,Effects of Mirtazapine on Appetite in Advanced Cancer Patients,M.D. Anderson Cancer Center,Phase 2,2025-12-31,"Advanced Cancer, Anorexia, Weight Loss","(None, 0)",,,0.0,18
NCT04560673,Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy,M.D. Anderson Cancer Center,Phase 2,2025-12-31,"Chemotherapy-Induced Peripheral Neuropathy, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm","(None, 0)",,,0.0,18
NCT06316856,CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies,Beijing GoBroad Hospital,Phase 2,2025-12-31,"T-Cell Acute Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia","(None, 0)",,,0.0,18
NCT03937830,"Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma",National Cancer Institute (NCI),Phase 2,2025-12-31,"Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma","(None, 0)",,,0.0,18
NCT06114940,Perioperative TORIPALIMAB Plus LENVATINIB in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PLUTO),"Jinling Hospital, China",Phase 2,2025-12-31,Renal Cell Carcinoma (RCC),"(None, 0)",,,0.0,18
NCT03269669,"Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma",National Cancer Institute (NCI),Phase 2,2025-12-31,"Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma","(None, 0)",,,0.0,18
NCT03768570,Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer,Canadian Cancer Trials Group,Phase 2,2025-12-31,Bladder Cancer,"(None, 0)",,,0.0,18
NCT06410651,Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma,"Cancer Institute and Hospital, Chinese Academy of Medical Sciences",Phase 2,2025-12-31,"Esophageal Cancer, Nimotuzumab, Chemoradiotherapy","(None, 0)",,,0.0,18
NCT06752720,Intracerebral Autologous Stem Cell Therapy for Chronic Stroke Patients,Hokkaido University Hospital,Phase 2,2025-12-31,"Stroke, Stroke, Ischemic, Stroke; Sequelae","(None, 0)",,,0.0,18
NCT04702880,"A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer",Bristol-Myers Squibb,Phase 2,2025-12-31,Extensive-stage Small Cell Lung Cancer,"('BMY', 100)",,,0.0,18
NCT06157502,Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY),Beijing Tiantan Hospital,Phase 3,2025-12-31,"Ischemic Stroke, Acute","(None, 0)",,,0.0,18
NCT04522544,Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC,Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest,Phase 2,2025-12-31,"Hepatocellular Carcinoma Non-resectable, HCC","(None, 0)",,,0.0,18
NCT03603405,HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM,The Methodist Hospital Research Institute,Phase 2,2025-12-31,"Glioblastoma, Anaplastic Astrocytoma","(None, 0)",,,0.0,18
NCT06341595,Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM,The First Affiliated Hospital with Nanjing Medical University,Phase 2,2025-12-31,"Gastric Cancer, Gastric Cancer Metastatic to Regional Lymph Nodes","(None, 0)",,,0.0,18
NCT03131908,Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss,M.D. Anderson Cancer Center,Phase 2,2025-12-31,"Melanoma and Other Malignant Neoplasms of Skin, Metastatic Melanoma","(None, 0)",,,0.0,18
NCT05893511,EUS-GBD vs Antibiotics for Patients at High Risk for Cholecystectomy,Chinese University of Hong Kong,Phase 3,2025-12-31,Acute Cholecystitis,"(None, 0)",,,0.0,18
NCT04331119,Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas,Washington University School of Medicine,Phase 2,2025-12-31,T-Cell Lymphoma,"(None, 0)",,,0.0,18
NCT05974449,Lactobacillus Vaginalis Capsules for Treatment of Vulvovaginal Atrophy in Young Breast Cancer Patients,The First Affiliated Hospital with Nanjing Medical University,Phase 2,2025-12-31,Breast Cancer Female,"(None, 0)",,,0.0,18
NCT03565913,Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V,University of Texas Southwestern Medical Center,Phase 3,2025-12-31,CKD Stage 5,"(None, 0)",,,0.0,18
NCT05600660,"Orelabrutinib,Rituximab and Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma","Second Affiliated Hospital, School of Medicine, Zhejiang University",Phase 2,2025-12-31,Primary Central Nervous System Lymphoma,"(None, 0)",,,0.0,18
NCT06717074,"A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of RBD4059 in Participants With Stable Coronary Artery Disease",Ribocure Pharmaceuticals AB,Phase 2,2025-12-31,Stable Coronary Artery Disease CAD,"(None, 0)",,,0.0,18
NCT04263831,Low Dose IL-2 for the Treatment of Crohn's Disease,Boston Children's Hospital,Phase 2,2025-12-31,Crohn Disease,"(None, 0)",,,0.0,18
NCT05437341,PSMA/CD70 Bi-specific CAR-T Cell Therapy,Shenzhen Geno-Immune Medical Institute,Phase 2,2025-12-31,Cancer Disease,"(None, 0)",,,0.0,18
NCT03654053,Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis,VA Office of Research and Development,Phase 3,2025-12-31,Cirrhosis,"(None, 0)",,,0.0,18
NCT05956639,Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC,The First Affiliated Hospital with Nanjing Medical University,Phase 3,2025-12-31,Metastatic Hormone-Sensitive Prostate Cancer (mHSPC),"(None, 0)",,,0.0,18
NCT04360681,Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in Veterans,Pharmacotherapies for Alcohol and Substance Use Disorders Alliance,Phase 2,2025-12-31,"Post Traumatic Stress Disorder, Opioid-use Disorder","(None, 0)",,,0.0,18
NCT04049539,Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction,Ohio State University Comprehensive Cancer Center,Phase 2,2025-12-31,"Blasts More Than 5 Percent of Bone Marrow Nucleated Cells, Persistent Disease, Refractory Acute Myeloid Leukemia","(None, 0)",,,0.0,18
NCT05012631,Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease,"Children's Hospital Medical Center, Cincinnati",Phase 2,2025-12-31,"Sickle Cell Disease, Diffuse Myocardial Fibrosis","(None, 0)",,,0.0,18
NCT04847505,68Ga-DOTA-TATE PET/CT Imaging in NETs,Centre de recherche du Centre hospitalier universitaire de Sherbrooke,Phase 3,2025-12-31,Neuroendocrine Tumors,"(None, 0)",,,0.0,18
NCT06429839,Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients,"Cancer Institute and Hospital, Chinese Academy of Medical Sciences",Phase 2,2025-12-31,"Esophageal Cancer, Nimotuzumab, Chemoradiotherapy","(None, 0)",,,0.0,18
NCT04691661,"Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease","Il-Yang Pharm. Co., Ltd.",Phase 2,2025-12-31,Parkinson Disease,"(None, 0)",,,0.0,18
NCT04939142,"A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)",Antengene Corporation,Phase 3,2025-12-31,Relapsed or Refractory Multiple Myeloma,"(None, 0)",,,0.0,18
NCT06190639,A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC,Zhejiang Cancer Hospital,Phase 2,2025-12-31,Esophageal Squamous Cell Carcinoma,"(None, 0)",,,0.0,18
NCT06214143,A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors,"Shanghai Pharmaceuticals Holding Co., Ltd",Phase 2,2025-12-31,Advanced Solid Tumors,"(None, 0)",,,0.0,18
NCT05437328,GD2/CD56 Bi-specific CAR-T Cell Therapy,Shenzhen Geno-Immune Medical Institute,Phase 2,2025-12-31,Malignant Disease,"(None, 0)",,,0.0,18
NCT05719428,Neural Network-based Treatment Decision Support Tool in Patients With Refractory Solid Organ Malignancies,"National University Hospital, Singapore",Phase 2,2025-12-31,Solid Organ Malignancies,"(None, 0)",,,0.0,18
NCT05474729,Minocycline for Chronic Autoimmune Uveitis,Sun Yat-sen University,Phase 2,2025-12-31,"Minocycline, Uveitis, Retinal Degeneration","(None, 0)",,,0.0,18
NCT06166836,a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors,"InxMed (Shanghai) Co., Ltd.",Phase 2,2025-12-31,Solid Tumor,"(None, 0)",,,0.0,18
NCT06223828,Azithromycin for Critical Asthma - Pediatrics,Johns Hopkins All Children's Hospital,Phase 3,2025-12-31,"Pediatric Asthma, Critical Illness","(None, 0)",,,0.0,18
NCT06880419,Anti-CD25 rhMAb for aGVHD Prevention in High-Risk Adults Using the daGOAT Model,"Institute of Hematology & Blood Diseases Hospital, China",Phase 2,2025-12-31,Acute Graft-versus-Host Disease,"(None, 0)",,,0.0,18
NCT03317158,"Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder","Noah Hahn, M.D.",Phase 2,2025-12-31,"Urothelial Carcinoma, Bladder Cancer","(None, 0)",,,0.0,18
NCT06006143,Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2,Yale University,Phase 2,2025-12-31,"Alcohol Use Disorder, Hiv, Tobacco Use Disorder","(None, 0)",,,0.0,18
NCT03482479,Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis,University of Pennsylvania,Phase 2,2025-12-31,"Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Giant Cell Arteritis","(None, 0)",,,0.0,18
NCT05744427,Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors,"Jiangsu Alphamab Biopharmaceuticals Co., Ltd",Phase 2,2025-12-31,Advanced Solid Tumor,"(None, 0)",,,0.0,18
NCT03952299,Oxybutynin for Post-surgical Bladder Pain and Urgency,"University of California, Davis",Phase 3,2025-12-31,"Overactive Bladder Syndrome, Neuropathic Bladder","(None, 0)",,,0.0,18
NCT05643534,Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years,Ardelyx,Phase 3,2025-12-31,Irritable Bowel Syndrome With Constipation (IBS-C),"(None, 0)",,,0.0,18
NCT05153785,Perioperative Intravenous Lidocaine in Liver Surgery,Lund University Hospital,Phase 3,2025-12-31,"Liver Metastases, Liver Cancer, Postoperative Pain","(None, 0)",,,0.0,18
NCT04193215,V114 and Acute Otitis Media (V114-032/PNEU-ERA),Merck Sharp & Dohme LLC,Phase 3,2025-12-31,Acute Otitis Media (AOM),"('MRK', 100)",,,0.0,18
NCT02977715,JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo,Centers for Disease Control and Prevention,Phase 3,2025-12-31,Monkeypox Virus Infection,"(None, 0)",,,0.0,18
NCT03650764,Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma,Washington University School of Medicine,Phase 2,2025-12-31,Head and Neck Squamous Cell Carcinoma,"(None, 0)",,,0.0,18
NCT05121051,"Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers",National Cancer Institute (NCI),Phase 2,2025-12-31,Cigarette Smoking-Related Carcinoma,"(None, 0)",,,0.0,18
NCT04875611,Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment,Maria Sklodowska-Curie National Research Institute of Oncology,Phase 2,2025-12-31,Nasopharyngeal Cancer,"(None, 0)",,,0.0,18
NCT05214391,"A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia","Institute of Hematology & Blood Diseases Hospital, China",Phase 2,2025-12-31,"Immune Thrombocytopenia, Treatment","(None, 0)",,,0.0,18
NCT06888531,Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma,Henan Cancer Hospital,Phase 2,2025-12-31,Esophageal Malignant Neoplasm Primary,"(None, 0)",,,0.0,18
NCT07022535,Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer,The University of Hong Kong,Phase 2,2025-12-31,"Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer","(None, 0)",,,0.0,18
NCT06244992,PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors,"Pyrotech Therapeutics, Inc.",Phase 2,2025-12-31,Locally Advanced or Metastatic Solid Tumors,"('PTCT', 89)",,,0.0,18
NCT07085988,Effect of Nutritional Management on Patients With Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma,Jiangxi Provincial Cancer Hospital,Phase 2,2025-12-31,Nasopharyngeal Carcinoma (NPC),"(None, 0)",,,0.0,18
NCT06794593,Effect Camostat for Kidney Protection in Chronic Kidney Disease,Odense University Hospital,Phase 2,2025-12-31,Chronic Kidney Disease(CKD),"(None, 0)",,,0.0,18
NCT06880913,Nanobody-Based CD19/CD22 Tandem Dual CAR-T Therapy for R/R B-ALL,Peking University People's Hospital,Phase 2,2025-12-31,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,"(None, 0)",,,0.0,18
NCT06332092,FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma,Fulgent Pharma LLC.,Phase 2,2025-12-31,Head and Neck Squamous Cell Carcinoma,"(None, 0)",,,0.0,18
NCT06232577,5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial,M.D. Anderson Cancer Center,Phase 2,2025-12-31,Intra-abdominal Cancer,"(None, 0)",,,0.0,18
NCT04517214,Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma,Fudan University,Phase 2,2025-12-31,Nasopharyngeal Carcinoma,"(None, 0)",,,0.0,18
NCT04104893,A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation,VA Office of Research and Development,Phase 2,2025-12-31,Metastatic Castration Resistant Prostate Cancer,"(None, 0)",,,0.0,18
NCT04317105,"Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN",National Cancer Institute (NCI),Phase 2,2025-12-31,"Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Unresectable Malignant Solid Neoplasm","(None, 0)",,,0.0,18
NCT06445881,Efficacy and Safety of Modified Si Jun Zi Tang in Perioperative NSCLC Treatment,First Affiliated Hospital of Zhejiang University,Phase 2,2025-12-31,"Non Small Cell Lung Cancer, Perioperative Complication","(None, 0)",,,0.0,18
NCT05623267,Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT,Sun Yat-sen University,Phase 3,2025-12-31,Limited Stage Small Cell Lung Cancer,"(None, 0)",,,0.0,18
NCT07099222,"Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks",University of Arizona,Phase 2,2025-12-31,"Postoperative Pain, Nausea and Vomiting, Postoperative, Dizziness","(None, 0)",,,0.0,18
NCT05551507,IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer,"InxMed (Shanghai) Co., Ltd.",Phase 2,2025-12-31,Platinum-resistant Ovarian Cancer,"(None, 0)",,,0.0,18
NCT03085004,CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts,Milton S. Hershey Medical Center,Phase 3,2025-12-31,"Pancreatic Cyst, EUS-FNA","(None, 0)",,,0.0,18
NCT05147844,Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma,Xinqiao Hospital of Chongqing,Phase 2,2025-12-31,Nasopharyngeal Carcinoma,"(None, 0)",,,0.0,18
NCT05786040,Tafasitamab and Rituximab for Front-Line Treatment of Post-Transplant Lymphoproliferative Disorder,Timothy Voorhees,Phase 2,2025-12-31,"Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder, Polymorphic Post-Transplant Lymphoproliferative Disorder","(None, 0)",,,0.0,18
NCT04984343,Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer,Weill Medical College of Cornell University,Phase 2,2025-12-31,Prostate Cancer,"(None, 0)",,,0.0,18
NCT06839989,"An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC","Institute of Tropical Medicine, Belgium",Phase 2,2025-12-31,Mpox (Monkeypox),"(None, 0)",,,0.0,18
NCT04770025,A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol,The Mind Research Network,Phase 2,2025-12-31,Alcohol Use Disorder,"(None, 0)",,,0.0,18
NCT07209878,"68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI",First Affiliated Hospital of Fujian Medical University,Phase 3,2025-12-31,Prostate Cancer (Adenocarcinoma),"(None, 0)",,,0.0,18
NCT06301399,Rituximab Combined With Prior Therapy in Advanced Hepatocellular Carcinoma: Efficacy & Safety Study,Tianjin Medical University Cancer Institute and Hospital,Phase 2,2025-12-31,Advanced Hepatocellular Carcinoma,"(None, 0)",,,0.0,18
NCT05481476,Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer,Sun Yat-sen University,Phase 2,2025-12-31,Pancreatic Neoplasms,"(None, 0)",,,0.0,18
NCT04732416,HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI),Hanmi Pharmaceutical Company Limited,Phase 2,2025-12-31,Congenital Hyperinsulinism,"(None, 0)",,,0.0,18
NCT05753826,Adebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian Cancer.,Fujian Cancer Hospital,Phase 2,2025-12-31,"Ovarian Neoplasms, Ovarian Diseases","(None, 0)",,,0.0,18
NCT04824014,4FMFES-PET Imaging of ER+ Advanced Breast Cancers,Centre de recherche du Centre hospitalier universitaire de Sherbrooke,Phase 2,2025-12-31,ER+ Breast Cancer,"(None, 0)",,,0.0,18
NCT06249854,Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer,Korea Institute of Oriental Medicine,Phase 2,2025-12-31,Non-small Cell Lung Cancer,"(None, 0)",,,0.0,18
NCT04466683,Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia,Ohio State University Comprehensive Cancer Center,Phase 2,2025-12-31,"Covid-19, Sars-CoV2, Pneumonia","(None, 0)",,,0.0,18
NCT05566041,"A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer","EpicentRx, Inc.",Phase 3,2025-12-31,"Carcinoma, Small Cell Lung","(None, 0)",,,0.0,18
NCT02286687,"Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes",M.D. Anderson Cancer Center,Phase 2,2025-12-31,"Advanced Malignant Neoplasm, ATM Gene Mutation, BRCA1 Gene Mutation","(None, 0)",,,0.0,18
NCT04984226,Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD,"University of California, Davis",Phase 2,2025-12-31,"Chronic Kidney Diseases, Metabolic Acidosis, Fatigue","(None, 0)",,,0.0,18
NCT05464784,"MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia",MediciNova,Phase 2,2025-12-31,"Diabetes Mellitus, Type 2, Hypertriglyceridemia, Non-Alcoholic Fatty Liver Disease","(None, 0)",,,0.0,18
NCT04807257,Auger Molecular Therapy (AMT) for Malignant Cutaneous Lesions Treatment,"NanoRay Biotech Co., Ltd.",Phase 2,2025-12-31,Malignant Fungating Wound,"(None, 0)",,,0.0,18
NCT05353361,A Phase Ib/II Study of SHR-A1811 Injection in Breast Cancer,"Jiangsu HengRui Medicine Co., Ltd.",Phase 2,2025-12-31,Breast Cancer,"(None, 0)",,,0.0,18
NCT04452500,Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study),VA Office of Research and Development,Phase 2,2025-12-31,PTSD,"(None, 0)",,,0.0,18
NCT05926960,"A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma",Pfizer,Phase 2,2025-12-31,Melanoma,"('PFE', 100)",,,0.0,18
NCT06148402,Fruquintinib Plus Camrelizumab and Capecitabine as Salvage Therapy After Progression on FOLFOXIRI-based First-line Treatment in Patients With Unresectable/Metastatic Colorectal Cancer,Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University,Phase 2,2025-12-31,Unresectable/Metastatic Colorectal Cancer,"(None, 0)",,,0.0,18
NCT06016062,A Study of RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors,"RemeGen Co., Ltd.",Phase 2,2025-12-31,Solid Tumor,"(None, 0)",,,0.0,18
NCT06423170,A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs,Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University,Phase 2,2025-12-31,Unresectable Gallbladder Cancer,"(None, 0)",,,0.0,18
NCT05768997,High Dose IV Iron Plus ESA in Chemotherapy-induced Anemia,Hallym University Medical Center,Phase 3,2025-12-31,Anemia,"(None, 0)",,,0.0,18
NCT05884320,Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers,M.D. Anderson Cancer Center,Phase 2,2025-12-31,"Gland, Salivary Gland Cancers","(None, 0)",,,0.0,18
NCT07161011,Phase 2b Controlled Study of Dosing Techniques - Part B,IVIEW Therapeutics Inc.,Phase 2,2025-12-31,Dry Eye,"('MRTX', 84)",,,0.0,18
NCT04680442,Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction,Population Health Research Institute,Phase 2,2025-12-31,"Breast Cancer, Heart Failure","(None, 0)",,,0.0,18
NCT05178992,Use of Socially Assistive Robots for Long Term Care Older Adults With Cognitive Impairment and Apathy,Vanderbilt University,Phase 2,2025-12-31,Alzheimer Disease,"(None, 0)",,,0.0,18
NCT01587352,Vorinostat in Treating Patients With Metastatic Melanoma of the Eye,National Cancer Institute (NCI),Phase 2,2025-12-31,"Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7","(None, 0)",,,0.0,18
NCT05253118,Relapsed or Refractory Primary Diffuse Large B-cell Lymphoma (DLBCL) of the Central Nervous System (CNS),Seoul National University Hospital,Phase 2,2025-12-31,DLBCL,"(None, 0)",,,0.0,18
NCT06183814,A Study of EXG102-031 in Participants With wAMD,Hangzhou Jiayin Biotech Ltd,Phase 2,2025-12-31,Neovascular Age-related Macular Degeneration,"(None, 0)",,,0.0,18
NCT06422858,Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma,Zhejiang Cancer Hospital,Phase 2,2025-12-31,Locally Advanced Inoperable Esophageal Squamous Cell Carcinoma,"(None, 0)",,,0.0,18
NCT04400994,IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus,The University of Hong Kong,Phase 2,2025-12-31,Pemphigus,"(None, 0)",,,0.0,18
NCT06829355,"""Thymalfasin Immunotherapy Study with Triple Regimen in Advanced MSS/pMMR Colorectal Cancer""",Beijing Friendship Hospital,Phase 2,2025-12-31,MCRC,"(None, 0)",,,0.0,18
NCT03565783,Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery,M.D. Anderson Cancer Center,Phase 2,2025-12-31,"Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck, Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","(None, 0)",,,0.0,18
NCT05975307,Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation,Sun Yat-sen University,Phase 2,2025-12-31,"Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy","(None, 0)",,,0.0,18
NCT07163819,Effect of Probiotic Intervention on Travel-Related Health Conditions During Short-Term Overseas Travel,Universiti Sains Malaysia,Phase 2,2025-12-31,Healthy Adults,"(None, 0)",,,0.0,18
NCT06267001,A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy,Hoffmann-La Roche,Phase 3,2025-12-31,Non-small Cell Lung Cancer (NSCLC),"('RHHBY', 100)",,,0.0,18
NCT05896007,Zanubrutinib Combined With Rituximab and Chemotherapy for Newly-Diagnosed PCNSLBCL Patients Intolerant to HSCT,Ruijin Hospital,Phase 2,2025-12-31,PCNSL,"(None, 0)",,,0.0,18
NCT04523493,Phase III Study of Toripalimab（JS001） Combined With Lenvatinib for Advanced HCC,"Shanghai Junshi Bioscience Co., Ltd.",Phase 3,2025-12-31,Advanced Hepatocellular Carcinoma (HCC),"(None, 0)",,,0.0,18
NCT05237960,Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia,University of Arizona,Phase 2,2025-12-31,"Erythroplakia, Oral Leukoplakia","(None, 0)",,,0.0,18
NCT06774222,A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG,Henan Cancer Hospital,Phase 2,2025-12-31,Gastric/Gastroesophageal Junction Adenocarcinoma,"(None, 0)",,,0.0,18
NCT04516135,Single Fraction or Multi-fraction Palliative Radiation Therapy for the Improvement of Quality of Life in Patients With Metastatic Gynecologic Cancers,M.D. Anderson Cancer Center,Phase 2,2025-12-31,Metastatic Malignant Female Reproductive System Neoplasm,"(None, 0)",,,0.0,18
NCT04594850,Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously,"Pharmicell Co., Ltd.",Phase 2,2025-12-31,Erectile Dysfunction,"(None, 0)",,,0.0,18
NCT04687176,Frontline Oral Arsenic Trioxide for APL,The University of Hong Kong,Phase 2,2025-12-31,Acute Promyelocytic Leukemia,"(None, 0)",,,0.0,18
NCT05681260,Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children with Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL),"Children's Cancer Group, China",Phase 3,2025-12-31,T-cell Lymphoblastic Lymphoma,"(None, 0)",,,0.0,18
NCT02148796,Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness,University of Arizona,Phase 2,2025-12-31,"Asthma, Wheezing","(None, 0)",,,0.0,18
NCT05393674,Fedratinib in Combination with Nivolumab,Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest,Phase 2,2025-12-31,"Primary Myelofibrosis, Secondary Myelofibrosis","(None, 0)",,,0.0,18
NCT07236476,Identify Effective Doses of LY01021 in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART),Luye Pharma Group Ltd.,Phase 2,2025-12-31,Assisted Reproduction,"(None, 0)",,,0.0,18
NCT06205927,Randomized Study of Carbon Ion Boost in Hypoxic Lesions for Locally Advanced Non-small Cell Lung Cancer,Jian Chen,Phase 2,2025-12-31,Non-small Cell Lung Cancer,"(None, 0)",,,0.0,18
NCT00496119,Proton Beam Therapy for Chordoma Patients,M.D. Anderson Cancer Center,Phase 2,2025-12-31,Chordoma,"(None, 0)",,,0.0,18
NCT03066206,Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC,M.D. Anderson Cancer Center,Phase 2,2025-12-31,"EGFR Exon 20 Mutation, ERBB2 Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma","(None, 0)",,,0.0,18
NCT04305548,Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma,Italian Sarcoma Group,Phase 2,2025-12-31,Mesenchymal Chondrosarcoma,"(None, 0)",,,0.0,18
NCT04067037,Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma,Henan Cancer Hospital,Phase 2,2025-12-31,Classical Hodgkin Lymphoma,"(None, 0)",,,0.0,18
NCT05835999,Everolimus Aging Study,"University of Wisconsin, Madison",Phase 2,2025-12-31,"Aging, Insulin Resistance","(None, 0)",,,0.0,18
NCT06540352,"A Study to Select the Dose and Evaluate the Effectiveness and Safety of the Drug Refralon®, Tablets, 1 mg for Long-term Use to Prevent Recurrence of Atrial Fibrillation/Flutter After Terminating Its Persistent Form","National Medical Research Center for Cardiology, Ministry of Health of Russian Federation",Phase 2,2025-12-31,"Atrial Fibrillation, Atrial Flutter","(None, 0)",,,0.0,18
NCT06348602,Evaluation of Safety & Efficacy for the Prevention of Ocular GVHD With Ophthalmic Tacrolimus vs Cyclosporine in Allo-HSCT,Hospital Universitario Dr. Jose E. Gonzalez,Phase 2,2025-12-31,Ocular Graft-versus-host Disease,"(None, 0)",,,0.0,18
NCT03814317,Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension,University of Florida,Phase 2,2025-12-31,"Sarcoidosis, Precapillary Pulmonary Hypertension, Interstitial Lung Disease","(None, 0)",,,0.0,18
NCT00967785,A Phase I Study of Mozobil in the Treatment of Patients With WHIMS,National Institute of Allergy and Infectious Diseases (NIAID),Phase 2,2025-12-31,"Leukopenia, Neutropenia, Infections","(None, 0)",,,0.0,18
NCT05058287,Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression,"Hospital for Special Surgery, New York",Phase 3,2025-12-31,"Opioid Use, Lumbar Spinal Stenosis, Pain, Postoperative","(None, 0)",,,0.0,18
NCT06091332,"Hemorrhagic Brainstem Cavernous Malformations Treatment With Sirolimus: aSingle Centre, Randomized, Placebo-controlled Pilot Trial",Huashan Hospital,Phase 2,2025-12-31,"Cavernous Malformations, Intracerebral Hemorrhage, Brainstem Stroke","(None, 0)",,,0.0,18
NCT04680026,A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF),"HUYABIO International, LLC.",Phase 2,2025-12-31,Atrial Fibrillation,"(None, 0)",,,0.0,18
NCT06143748,Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006),Sun Yat-sen University,Phase 2,2025-12-31,Esophagus Cancer,"(None, 0)",,,0.0,18
NCT04115163,Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer,Anne Noonan,Phase 2,2025-12-31,"Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8","(None, 0)",,,0.0,18
NCT03854032,Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck,Thomas Jefferson University,Phase 2,2025-12-31,"Lip, Oral Cavity Squamous Cell Carcinoma, Pharynx","(None, 0)",,,0.0,18
NCT05554393,Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial),National Cancer Institute (NCI),Phase 2,2025-12-31,Acute Myeloid Leukemia,"(None, 0)",,,0.0,18
NCT06306456,A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC,"Suzhou Genhouse Bio Co., Ltd.",Phase 2,2025-12-31,Non-Small Cell Lung Cancer With EGFR Mutation,"(None, 0)",,,0.0,18
NCT06705530,"A Study to Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders","National Research Center for Hematology, Russia",Phase 2,2025-12-31,"Non-Hodgkin Lymphoma, B-cell, Acute Lymphoblastic Leukemia ALL","(None, 0)",,,0.0,18
NCT02568267,"Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)",Hoffmann-La Roche,Phase 2,2025-12-31,"Breast Cancer, Cholangiocarcinoma, Colorectal Cancer","('RHHBY', 100)",,,0.0,18
NCT04046159,Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ,National Taiwan University Hospital,Phase 3,2025-12-31,Breast Ductal Carcinoma in Situ,"(None, 0)",,,0.0,18
NCT06737081,SAL-0951 in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid Malignancies,"Shenzhen Salubris Pharmaceuticals Co., Ltd.",Phase 2,2025-12-31,Anemia,"(None, 0)",,,0.0,18
NCT05056402,An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old,Xiamen University,Phase 3,2025-12-31,"Cervical Cancer, Condylomata Acuminata","(None, 0)",,,0.0,18
NCT06799546,A Phase III Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Are Naive to Complement Inhibitor Therapy,"Haisco Pharmaceutical Group Co., Ltd.",Phase 3,2025-12-31,PNH,"(None, 0)",,,0.0,18
NCT05619302,Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis,Brigham and Women's Hospital,Phase 3,2025-12-31,Cardiac Amyloidosis,"(None, 0)",,,0.0,18
NCT07140380,Phase 2b Controlled Study,IVIEW Therapeutics Inc.,Phase 2,2025-12-31,Dry Eye Disease,"('MRTX', 84)",,,0.0,18
NCT06500637,TB006 for Autism Spectrum Disorder,Rossignol Medical Center,Phase 2,2025-12-31,Autism Spectrum Disorder,"(None, 0)",,,0.0,18
NCT04486781,A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma,"Vasgene Therapeutics, Inc",Phase 2,2025-12-31,Metastatic Urothelial Carcinoma,"('VYGR', 88)",,,0.0,18
NCT06135350,Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Phase 2,2025-12-31,"Gram Negative Pneumonia, Gram-Negative Bacterial Infections, Bacteremia Caused by Gram-Negative Bacteria","(None, 0)",,,0.0,18
NCT05586997,Rapid Maxillary Expansion with Low Level Laser Therapy,"National Research Centre, Egypt",Phase 3,2025-12-31,"Crossbite, Malocclusion, Cross Bite","(None, 0)",,,0.0,18
NCT06706713,Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer,BeBetter Med Inc,Phase 2,2025-12-31,"Non-Small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation","(None, 0)",,,0.0,18
NCT07058688,A Study of NTRX-07 in Participants With Alzheimer's Disease,"NeuroTherapia, Inc.",Phase 2,2025-12-31,"Alzheimer Disease, Mild Cognitive Impairment","(None, 0)",,,0.0,18
NCT05827042,Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion,The First Affiliated Hospital of University of Science and Technology of China,Phase 3,2025-12-31,"Basilar Artery Occlusion, Acute Cerebrovascular Accident, Stroke Due to Basilar Artery Occlusion","(None, 0)",,,0.0,18
NCT06250959,RDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL.,Chen Suning,Phase 2,2025-12-31,"ALL, Adult, Philadelphia-Negative ALL","(None, 0)",,,0.0,18
NCT06404099,"RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)",Duke University,Phase 2,2025-12-31,"Long COVID, Long COVID-19, Hypersomnia","(None, 0)",,,0.0,18
NCT05077800,FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer,"Colin D. Weekes, M.D., PhD",Phase 2,2025-12-31,"Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic","(None, 0)",,,0.0,18
NCT06055244,Amantadine Therapy for Cognitive Impairment in Long COVID,Ohio State University,Phase 2,2025-12-31,"Long COVID, Post-COVID19 Condition, Post-Acute COVID19 Syndrome","(None, 0)",,,0.0,18
NCT03508232,Doxycycline to Protect Heart Muscle After Heart Attacks,University of Alberta,Phase 2,2025-12-31,"ST Segment Elevation Myocardial Infarction, Heart Failure","(None, 0)",,,0.0,18
NCT05776459,Efficacy and Safety of AC102 Compared to Steroids in Adults with Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL),AudioCure Pharma GmbH,Phase 2,2025-12-31,"Hearing Loss, Sensorineural","(None, 0)",,,0.0,18
NCT06478953,Impact of Rapid Pathogen Detection in ICU Patients With Suspected Pneumonia on Antimicrobial Therapy,Chinese University of Hong Kong,Phase 2,2025-12-31,"Pneumonia, Critically Ill","(None, 0)",,,0.0,18
NCT05669092,A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status,Zhejiang Cancer Hospital,Phase 3,2025-12-31,"Toripalimab, Radiation","(None, 0)",,,0.0,18
NCT06173817,The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients,Oslo University Hospital,Phase 3,2025-12-31,Methanol Poisoning,"(None, 0)",,,0.0,18
NCT04267978,Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas,Beijing Sanbo Brain Hospital,Phase 2,2025-12-31,"Glioblastoma, Recurrent, Lower Grade Glioma, Recurrent","(None, 0)",,,0.0,18
NCT03977493,IncobotulinumtoxinA (Xeomin) to Treat Focal Hand Dystonia,Alain Kaelin,Phase 3,2025-12-31,Focal Hand Dystonia,"(None, 0)",,,0.0,18
NCT05882513,Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer,"Second Affiliated Hospital, School of Medicine, Zhejiang University",Phase 2,2025-12-31,"NSCLC, Neoadjuvant Therapy","(None, 0)",,,0.0,18
NCT04905056,"A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules",Shanghai Zhongshan Hospital,Phase 2,2025-12-31,Progression,"(None, 0)",,,0.0,18
NCT03092856,Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer,University of Southern California,Phase 2,2025-12-31,"Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma","(None, 0)",,,0.0,18
NCT05260957,"CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL).",Lazaros Lekakis,Phase 2,2025-12-31,"Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma","(None, 0)",,,0.0,18
NCT03247088,"Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant",M.D. Anderson Cancer Center,Phase 2,2025-12-31,"Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia","(None, 0)",,,0.0,18
NCT06218810,"Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer",Fudan University,Phase 2,2025-12-31,"Metastatic Colorectal Cancer, Microsatellite Stable Colorectal Carcinoma, RAS Mutation","(None, 0)",,,0.0,18
NCT04877197,Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care,VA Office of Research and Development,Phase 3,2025-12-31,"Depression, Cardiovascular Diseases","(None, 0)",,,0.0,18
NCT06096857,Cardamom and Topical Roseomonas in Atopic Dermatitis,National Institute of Allergy and Infectious Diseases (NIAID),Phase 2,2026-01-01,"Atopic Dermatitis, Eczema","(None, 0)",,,0.0,19
NCT04835129,"Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma",Medical College of Wisconsin,Phase 2,2026-01-01,Multiple Myeloma,"(None, 0)",,,0.0,19
NCT05975749,Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer,Fudan University,Phase 2,2026-01-01,Gastric Cancer,"(None, 0)",,,0.0,19
NCT04205227,ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors,"ENB Therapeutics, Inc",Phase 2,2026-01-01,"Cancer, Melanoma, Ovary Cancer","('HRTX', 90)",,,0.0,19
NCT04921033,Exclusive Enteral Nutrition in Patients With Ileocaecal Crohn's Disease,Duzce University,Phase 3,2026-01-01,"Crohn Disease, Nutrient; Excess, Remission/Regression","(None, 0)",,,0.0,19
NCT05108870,TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers,University of Chicago,Phase 2,2026-01-01,"Human Papilloma Virus, HPV, HPV Positive Oropharyngeal Squamous Cell Carcinoma","(None, 0)",,,0.0,19
NCT06448052,Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation,Nguyen Ton Ngoc Huynh,Phase 2,2026-01-01,"Inflammatory Disease, Aging Problems, Obese","(None, 0)",,,0.0,19
NCT05907057,An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.,Servier Affaires Médicales,Phase 3,2026-01-01,Acute Myeloid Leukemia (AML),"(None, 0)",,,0.0,19
NCT06846086,Cardioprotective Effects of Melatonin in Patients With Cardiomyopathy,Tanta University,Phase 3,2026-01-01,Cardiomyopathies,"(None, 0)",,,0.0,19
NCT06031181,Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019),Fudan University,Phase 3,2026-01-01,"Lung Adenocarcinoma, Frozen Section, Sublobar Resection","(None, 0)",,,0.0,19
NCT05170503,Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma,Sun Yat-sen University,Phase 2,2026-01-01,Esophagogastric Junction Adenocarcinoma,"(None, 0)",,,0.0,19
NCT07073287,Efficacy of Cerebello-spinal Direct Current Stimulation (csDCS) on Functional Mobility in Chronic Stroke Patients,Universidade Federal de Pernambuco,Phase 2,2026-01-01,"Stroke Rehabilitation, Gait Disorders, Neurologic, tDCS","(None, 0)",,,0.0,19
NCT06145035,Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy,Roberto Bolli,Phase 2,2026-01-01,Ischemic Heart Disease,"(None, 0)",,,0.0,19
NCT06762080,Intrathecal Combination of Programmed Death-1 (PD-1)/Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Bispecific Antibody and Pemetrexed for Leptomeningeal Metastasis,Guangzhou Medical University,Phase 2,2026-01-01,Leptomeningeal Metastasis,"(None, 0)",,,0.0,19
NCT03109288,"Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)",National Institute of Allergy and Infectious Diseases (NIAID),Phase 2,2026-01-01,Multiple Sclerosis,"(None, 0)",,,0.0,19
NCT07037680,Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT,JIANYANG WANG,Phase 2,2026-01-01,"Locally Advanced Non-Small Cell Lung Cancer, Thoracic Radiotherapy, Safety","(None, 0)",,,0.0,19
NCT05968937,Vaginal Baclofen Suppositories in Chronic Pelvic Pain,University of Louisville,Phase 2,2026-01-01,Chronic Pelvic Pain Syndrome,"(None, 0)",,,0.0,19
NCT04384484,Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma,ADC Therapeutics S.A.,Phase 3,2026-01-01,"Relapsed Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma","('CRSP', 81)",,,0.0,19
NCT05767879,(Neo)Adjuvant BRAF/MEK Inhibition in pN1c Melanoma,Leiden University Medical Center,Phase 2,2026-01-01,"Melanoma Stage III, In-Transit Metastasis of Cutaneous Melanoma","(None, 0)",,,0.0,19
NCT06900010,A Study to Evaluate CM336 in Adults with Autoimmune Bullous Disease,Shandong First Medical University,Phase 2,2026-01-01,Autoimmune Bullous Disease,"(None, 0)",,,0.0,19
NCT06755554,Investigation of Impact of Indocyanine Green on Volume of Lymphadenectomy in Resectable Gastric Cancer,Ukrainian Society of Clinical Oncology,Phase 3,2026-01-01,"Gastric Cancer Stage II, Gastric Cancer Stage III, Gastric Cancer","(None, 0)",,,0.0,19
NCT03579875,Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders,"Masonic Cancer Center, University of Minnesota",Phase 2,2026-01-01,"Fanconi Anemia, Severe Aplastic Anemia, Myelodysplastic Syndromes","(None, 0)",,,0.0,19
NCT04160910,5HTP Regulation Of Asthma In Children,Indiana University,Phase 2,2026-01-05,Mild or Moderate Asthma With Allergic Sensitization,"(None, 0)",,,0.0,23
NCT06291376,Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN),"Alexion Pharmaceuticals, Inc.",Phase 3,2026-01-05,"Immunoglobulin A Nephropathy, IgAN","('ALXN', 100)",,,0.0,23
NCT03604978,Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma,National Cancer Institute (NCI),Phase 2,2026-01-06,"Grade 2 Meningioma, Grade 3 Meningioma, Recurrent Meningioma","(None, 0)",,,0.0,24
NCT05419050,Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia,National Institute of Dental and Craniofacial Research (NIDCR),Phase 2,2026-01-09,Fibrous Dysplasia,"(None, 0)",,,0.0,27
NCT05978037,A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines,University of Oxford,Phase 2,2026-01-10,"Malaria, Malaria,Falciparum, Parasitic Disease","(None, 0)",,,0.0,28
NCT05672355,A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia,City of Hope Medical Center,Phase 2,2026-01-12,"Chronic Lymphocytic Leukemia, COVID-19 Infection","(None, 0)",,,0.0,30
NCT02684292,Study of Pembrolizumab (MK-3475) vs. Brentuximab Vedotin in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-204/KEYNOTE-204),Merck Sharp & Dohme LLC,Phase 3,2026-01-12,Hodgkin Lymphoma,"('MRK', 100)",,,0.0,30
NCT03552705,The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients,Stanford University,Phase 2,2026-01-14,Anterior Cruciate Ligament Reconstruction,"(None, 0)",,,0.0,32
NCT01409200,Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis,M.D. Anderson Cancer Center,Phase 2,2026-01-15,"Metastatic Malignant Neoplasm in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7","(None, 0)",,,0.0,33
NCT03523858,A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis,Hoffmann-La Roche,Phase 3,2026-01-15,Progressive Multiple Sclerosis (PMS),"('RHHBY', 100)",,,0.0,33
NCT02940301,Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma,Ohio State University Comprehensive Cancer Center,Phase 2,2026-01-15,Classical Hodgkin Lymphoma,"(None, 0)",,,0.0,33
NCT07096310,Comparison Between Carbapenems and Noncarbapenem Beta-lactam Antibiotics in Septic Burn Patients,Ain Shams University,Phase 2,2026-01-15,Sepsis,"(None, 0)",,,0.0,33
NCT05767359,CAR- PRISM (PRecision Intervention Smoldering Myeloma),Dana-Farber Cancer Institute,Phase 2,2026-01-15,"Multiple Myeloma, Smoldering Multiple Myeloma","(None, 0)",,,0.0,33
NCT04994808,Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia,Fred Hutchinson Cancer Center,Phase 2,2026-01-16,"Acute Myeloid Leukemia, Myelodysplastic Syndrome","(None, 0)",,,0.0,34
NCT07128615,A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA),AstraZeneca,Phase 2,2026-01-20,Influenza A,"('AZN', 100)",,,0.0,38
NCT01684397,Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer,Roswell Park Cancer Institute,Phase 2,2026-01-20,"Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer","(None, 0)",,,0.0,38
NCT05316688,"A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery",University of Washington,Phase 2,2026-01-20,"Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8","(None, 0)",,,0.0,38
NCT05564403,"Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)",National Cancer Institute (NCI),Phase 2,2026-01-21,"Advanced Biliary Tract Carcinoma, Advanced Gallbladder Carcinoma, Advanced Intrahepatic Cholangiocarcinoma","(None, 0)",,,0.0,39
NCT06839664,A Study of HS-20094 in Chinese Adults with Overweight or Obesity,"Jiangsu Hansoh Pharmaceutical Co., Ltd.",Phase 3,2026-01-27,"Overweight, Obesity","(None, 0)",,,0.0,45
NCT05399654,A Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors,Tallac Therapeutics,Phase 2,2026-01-27,Advanced or Metastatic Solid Tumors,"('CARA', 80)",,,0.0,45
NCT05672368,The da Vinci Single Port Robotic System for Use in Abdominal and Pelvic Surgical Procedures,City of Hope Medical Center,Phase 2,2026-01-27,Disease or Disorder,"(None, 0)",,,0.0,45
NCT05489289,A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection,Akeso,Phase 3,2026-01-28,Hepatocellular Carcinoma,"(None, 0)",,,0.0,46
NCT06593600,Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS),Regeneron Pharmaceuticals,Phase 2,2026-01-28,Postural Orthostatic Tachycardia Syndrome (POTS),"('REGN', 100)",,,0.0,46
NCT05251259,Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma,AstraZeneca,Phase 2,2026-01-29,Asthma,"('AZN', 100)",,,0.0,47
NCT05104853,"Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects with Primary Biliary Cholangitis","COUR Pharmaceutical Development Company, Inc.",Phase 2,2026-01-30,Primary Biliary Cholangitis,"(None, 0)",,,0.0,48
NCT05257018,R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse,Fudan University,Phase 2,2026-01-30,Diffuse Large B-cell Lymphoma,"(None, 0)",,,0.0,48
NCT04031456,Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients,Genesis Athens Clinic,Phase 3,2026-01-30,"Menopause, Premature, Menopause Related Conditions, Menopausal Syndrome","(None, 0)",,,0.0,48
NCT06721962,Treatment of Moderate to Severe Refractory Crohn's Disease,"Tr1X, Inc.",Phase 2,2026-01-30,Crohns Disease,"(None, 0)",,,0.0,48
NCT06711185,Effect of DAPAglifozin on MYOcardial Remodeling of Breast CANCER Patients Treated with Anthracycline Based Chemotherapy,"University of Campinas, Brazil",Phase 3,2026-01-30,Breast Cancer,"(None, 0)",,,0.0,48
NCT05438043,A Study of Daratumumab,"Janssen Research & Development, LLC",Phase 3,2026-01-30,Multiple Myeloma,"(None, 0)",,,0.0,48
NCT05660967,Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma,Genmab,Phase 2,2026-01-30,Diffuse Large B-Cell Lymphoma,"(None, 0)",,,0.0,48
NCT06895499,"Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.","Shanghai Huaota Biopharmaceutical Co., Ltd.",Phase 2,2026-01-30,Hidradenitis Suppurativa,"(None, 0)",,,0.0,48
NCT06490081,Trilaciclib Prevents Myelosuppression With Chemoradiotherapy,"Cancer Institute and Hospital, Chinese Academy of Medical Sciences",Phase 2,2026-01-30,Myelosuppression,"(None, 0)",,,0.0,48
NCT06616389,Study of ODX (OsteoDex) in Multiple Myeloma,DexTech Medical AB,Phase 2,2026-01-30,Multiple Myeloma,"(None, 0)",,,0.0,48
NCT03916978,Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women,Genesis Athens Clinic,Phase 3,2026-01-30,"Infertility, Female, Anovulatory Infertility, Menopause","(None, 0)",,,0.0,48
NCT04460872,Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury,North Florida Foundation for Research and Education,Phase 2,2026-01-30,"Spinal Cord Injury, Spinal Cord Injuries, Trauma, Nervous System","(None, 0)",,,0.0,48
NCT04906902,Acalabrutinib in CNSL,Dana-Farber Cancer Institute,Phase 2,2026-01-31,"Central Nervous System Lymphoma, Refractory Central Nervous System Lymphoma, Recurrent Central Nervous System Lymphoma","(None, 0)",,,0.0,49
NCT03162653,Effect of Allopurinol for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome,University Hospital Tuebingen,Phase 3,2026-01-31,"Encephalopathy, Hypoxic-Ischemic, Infant, Newborn, Diseases","(None, 0)",,,0.0,49
NCT05357482,Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia,"National Heart, Lung, and Blood Institute (NHLBI)",Phase 2,2026-01-31,"Sickle Cell Anemia, Beta Thalassemia","(None, 0)",,,0.0,49
NCT05835206,Further MT for Antibiotic-Resistant Bacterial Colonization in Inpatients,Emory University,Phase 2,2026-01-31,Multi-drug Resistant Organism,"(None, 0)",,,0.0,49
NCT05703425,The Effect of Sulfasalazine on CRH Levels in Pregnant Women,"Rutgers, The State University of New Jersey",Phase 2,2026-01-31,Preterm Birth,"(None, 0)",,,0.0,49
NCT03087071,Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer,M.D. Anderson Cancer Center,Phase 2,2026-01-31,"EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation","(None, 0)",,,0.0,49
NCT01344200,CELECOXIB Plasma and Cerebral Spinal Fluid Pharmacokinetics in Children,Children's Hospital of Eastern Ontario,Phase 2,2026-01-31,Pharmacokinetics of Celecoxib in Children,"(None, 0)",,,0.0,49
NCT06477146,Milk Thistle Clinical Trial in Pediatric NAFLD,University Hospitals Cleveland Medical Center,Phase 2,2026-01-31,Non-Alcoholic Fatty Liver Disease (NAFLD),"(None, 0)",,,0.0,49
NCT03663543,Intravenous Estrogen in Kidney Transplant Study,University of Pennsylvania,Phase 2,2026-01-31,Ischemia Reperfusion Injury,"(None, 0)",,,0.0,49
NCT04294810,A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer,Hoffmann-La Roche,Phase 3,2026-01-31,Non-Small Cell Lung Cancer,"('RHHBY', 100)",,,0.0,49
NCT01352520,"SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)",M.D. Anderson Cancer Center,Phase 2,2026-01-31,"CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma, Lymphoma, Primary Cutaneous Anaplastic Large Cell, Lymphomatoid Papulosis","(None, 0)",,,0.0,49
NCT05709782,Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC,M.D. Anderson Cancer Center,Phase 2,2026-01-31,Spinal Disease,"(None, 0)",,,0.0,49
NCT04820179,"Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer",University of Arizona,Phase 2,2026-01-31,"Pancreatic Cancer, Metastatic Pancreatic Cancer","(None, 0)",,,0.0,49
NCT06613880,Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia,"Institute of Hematology & Blood Diseases Hospital, China",Phase 2,2026-01-31,"Aplastic Anemia, TPO Receptor Agonists","(None, 0)",,,0.0,49
NCT05701215,Venetoclax After TKI to Target Persisting Stem Cells in CML,"Thomas Ernst, PD Dr. med.",Phase 2,2026-01-31,Chronic Myeloid Leukemia,"(None, 0)",,,0.0,49
NCT06046443,A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity,"Rhythm Pharmaceuticals, Inc.",Phase 2,2026-01-31,Hypothalamic Obesity,"('PHAT', 91)",,,0.0,49
NCT07089043,A Study in Subjects With Neurogenic Orthostatic Hypotension,"CuraSen Therapeutics, Inc.",Phase 2,2026-01-31,Neurogenic Orthostatic Hypotension,"('CARA', 89)",,,0.0,49
NCT04542148,Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes,University of Alabama at Birmingham,Phase 2,2026-01-31,"Diabetes Mellitus, Type 2, Preterm Birth, Pregnancy, High Risk","(None, 0)",,,0.0,49
NCT06793332,BrAin Metastasis in TripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC,Fudan University,Phase 2,2026-01-31,"Triple-Negative Breast Cancer (TNBC), Brain Metastases","(None, 0)",,,0.0,49
NCT04356209,"Improving Theempowerment in Patients With Severe Breast Fibrosis Radio-induced Treated by Pravastatin : Benefit of e-PROs (Electronic "" Patient Reported Outcome "") on Breast-related Quality of Life",Institut du Cancer de Montpellier - Val d'Aurelle,Phase 2,2026-01-31,Breast Cancer,"(None, 0)",,,0.0,49
NCT06799611,"An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia","Institute of Hematology & Blood Diseases Hospital, China",Phase 2,2026-01-31,"Immune Thrombocytopenia (ITP), Treatment","(None, 0)",,,0.0,49
NCT07167550,The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke,"Tatchempharmpreparaty, JSC",Phase 3,2026-01-31,"Stroke, Acute Stroke, Ischemic Stroke","(None, 0)",,,0.0,49
NCT04036682,A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer,Cullinan Therapeutics Inc.,Phase 2,2026-01-31,"Non Small Cell Lung Cancer, EGFR Exon 20 Mutation","('CARA', 83)",,,0.0,49
NCT06084819,Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia,Chinese PLA General Hospital,Phase 2,2026-01-31,Relapsed/Refractory Acute Myeloid Leukemia,"(None, 0)",,,0.0,49
NCT06530511,"Polatuzumab, Rituximab and Orelabrutinib Combination Regimen (PRO) in the Treatment of Elderly Frail Patients with Treatment-naive Non-GCB DLBCL",Affiliated Hospital of Nantong University,Phase 2,2026-02-01,Diffuse Large B Cell Lymphoma,"(None, 0)",,,0.0,50
NCT04242017,Long-term Better Than Short-term ADT With Salvage RT,Universitaire Ziekenhuizen KU Leuven,Phase 3,2026-02-01,Prostate Cancer,"(None, 0)",,,0.0,50
NCT03564340,Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers,Regeneron Pharmaceuticals,Phase 2,2026-02-01,"Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Recurrent Primary Peritoneal Cancer","('REGN', 100)",,,0.0,50
NCT04762069,A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme,"CNS Pharmaceuticals, Inc.",Phase 2,2026-02-01,"Glioblastoma Multiforme, Adult","('CRVS', 90)",,,0.0,50
NCT05600686,Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma,Joseph Tuscano,Phase 2,2026-02-01,"Double-Expressor Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements","(None, 0)",,,0.0,50
NCT05664841,The Impact of a Virtual Magic Trick Training Program,University of Alabama at Birmingham,Phase 2,2026-02-01,"Autism, Pervasive Developmental Disorder","(None, 0)",,,0.0,50
NCT02884648,Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery,M.D. Anderson Cancer Center,Phase 2,2026-02-01,"Malignant Neoplasms of Female Genital Organs, Ovarian Cancer, Fallopian Tube Cancer","(None, 0)",,,0.0,50
NCT06210971,Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer,Hebei Medical University Fourth Hospital,Phase 2,2026-02-01,Rectal Cancer,"(None, 0)",,,0.0,50
NCT05339074,Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression,Joshua Rosenblat,Phase 2,2026-02-01,"Bipolar Disorder, Bipolar Depression, Bipolar I Disorder","(None, 0)",,,0.0,50
NCT06241599,"A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)",Sun Yat-sen University,Phase 3,2026-02-01,Recurrent or Metastatic Nasopharyngeal Carcinoma,"(None, 0)",,,0.0,50
NCT02723994,A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia,Incyte Corporation,Phase 2,2026-02-01,Leukemia,"('INCY', 100)",,,0.0,50
NCT06843538,Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery,TriHealth Inc.,Phase 3,2026-02-01,Postoperative Urinary Retention (POUR),"(None, 0)",,,0.0,50
NCT04551807,Natural Versus Programmed Frozen Embryo Transfer (NatPro),JHSPH Center for Clinical Trials,Phase 3,2026-02-01,"Pregnancy Related, Pre-Eclampsia","(None, 0)",,,0.0,50
NCT07178522,A Study to Evaluate the Immunogenicity and Safety of an EV71 Vaccine (Envacgen®) in Children Aged 6 to <10 Years Compared to Children Aged 2 to <6 Years,Medigen Vaccine Biologics Corp.,Phase 3,2026-02-01,Enterovirus 71 Inactivated Vaccine,"(None, 0)",,,0.0,50
NCT05726396,A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis,University of Minnesota,Phase 2,2026-02-01,"Immune-related Colitis, Colitis","(None, 0)",,,0.0,50
NCT06253130,"A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors",Eikon Therapeutics,Phase 2,2026-02-01,Advanced Solid Tumor,"('BEAM', 82)",,,0.0,50
NCT04215731,Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer,Yanhong Deng,Phase 3,2026-02-01,Rectal Cancer,"(None, 0)",,,0.0,50
NCT06617858,Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment,M.D. Anderson Cancer Center,Phase 2,2026-02-01,Colorectal Cancer,"(None, 0)",,,0.0,50
NCT04620187,Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas,Dana-Farber Cancer Institute,Phase 2,2026-02-01,"Salivary Gland Cancer, HER2 Gene Mutation","(None, 0)",,,0.0,50
NCT06810167,Assessing Tenapanor as a Treatment of CF-related Constipation.,Massachusetts General Hospital,Phase 3,2026-02-01,"Cystic Fibrosis, Constipation","(None, 0)",,,0.0,50
NCT06514612,"LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops, Single Dose) in the Treatment of Acquired Blepharoptosis.",Santen SAS,Phase 3,2026-02-01,Acquired Blepharophimosis,"(None, 0)",,,0.0,50
NCT05947890,Evaluating the Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living With and Without HIV in South Africa,HIV Vaccine Trials Network,Phase 2,2026-02-02,"HIV I Infection, Tuberculosis","(None, 0)",,,0.0,51
NCT03548428,Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc),Centre Antoine Lacassagne,Phase 2,2026-02-04,"Sarcoma, Radiosurgery","(None, 0)",,,0.0,53
NCT06757504,Evaluate the Efficacy and Safety of TTYP01 Tablets in Adolescents and Children With ASD,"Shanghai Auzone Biological Technology Co., Ltd.",Phase 2,2026-02-06,Autism Spectrum Disorder (ASD),"(None, 0)",,,0.0,55
NCT05736419,A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT),Memorial Sloan Kettering Cancer Center,Phase 2,2026-02-09,"Sickle Cell Disease, Thalassemia, Beta, Thalassemia","(None, 0)",,,0.0,58
NCT05301608,Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought,Johns Hopkins University,Phase 2,2026-02-09,Healthy,"(None, 0)",,,0.0,58
NCT06248619,A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease,Amgen,Phase 3,2026-02-10,Thyroid Eye Disease,"('AMGN', 100)",,,0.0,59
NCT04586231,A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011),Merck Sharp & Dohme LLC,Phase 3,2026-02-11,"Carcinoma, Renal Cell","('MRK', 100)",,,0.0,60
NCT05380453,Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission,Novartis Pharmaceuticals,Phase 3,2026-02-11,Giant Cell Arteritis,"('NVS', 100)",,,0.0,60
NCT06446960,The Role of Peripheral Afferents in Modulating Post-stroke Central Pain,"Institut National de la Santé Et de la Recherche Médicale, France",Phase 3,2026-02-12,Stroke,"(None, 0)",,,0.0,61
NCT05742243,Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes,Melbourne Health,Phase 2,2026-02-13,"Type 1 Diabetes, Diabetes Mellitus, Type 1","(None, 0)",,,0.0,62
NCT07036601,Phase II Study of THDBH120 Injection in Overweight or Obese Subjects,"Tonghua Dongbao Pharmaceutical Co.,Ltd",Phase 2,2026-02-13,Overweight or Obese,"(None, 0)",,,0.0,62
NCT07246681,Lignin in Treatment of Helicobacter Pylori Infection,Zagazig University,Phase 3,2026-02-15,HELICOBACTER PYLORI INFECTIONS,"(None, 0)",,,0.0,64
NCT06268652,Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast Cancer,Sun Yat-sen University,Phase 3,2026-02-15,"Breast Cancer, Refractory Breast Carcinoma","(None, 0)",,,0.0,64
NCT06507371,Node-sparing Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Rectal Cancer,Sir Run Run Shaw Hospital,Phase 3,2026-02-15,Rectal Cancer,"(None, 0)",,,0.0,64
NCT04811560,A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1),"Janssen Research & Development, LLC",Phase 2,2026-02-16,"Acute Leukemias, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia","(None, 0)",,,0.0,65
NCT05703607,A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults,Pfizer,Phase 2,2026-02-17,"Shingles, Herpes Zoster Infection, Human","('PFE', 100)",,,0.0,66
NCT06589765,A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin,"Shandong Suncadia Medicine Co., Ltd.",Phase 3,2026-02-18,Type 2 Diabetes,"(None, 0)",,,0.0,67
NCT05821010,Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),Phase 2,2026-02-20,"Non Alcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease, Fecal Microbiota Transplantation","(None, 0)",,,0.0,69
NCT06037889,Efficacy and Safety of Tirofiban for Patients With BAD (BRANT),Peking Union Medical College Hospital,Phase 3,2026-02-22,Branch Atheromatous Disease,"(None, 0)",,,0.0,71
NCT05605496,NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies,Centre Leon Berard,Phase 2,2026-02-24,"Advanced Solid Tumors, Metastatic Solid Tumors","(None, 0)",,,0.0,73
NCT06299826,A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure,AstraZeneca,Phase 2,2026-02-24,Chronic Heart Failure,"('AZN', 100)",,,0.0,73
NCT05589896,A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies,"Ossium Health, Inc.",Phase 2,2026-02-25,"Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia","(None, 0)",,,0.0,74
NCT03508752,Neurocognitive Decline in Patients With Brain Metastases,University of Texas Southwestern Medical Center,Phase 2,2026-02-26,Brain Metastases,"(None, 0)",,,0.0,75
NCT04023552,Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD,Novartis Pharmaceuticals,Phase 3,2026-02-26,Cardiovascular Disease and Lipoprotein(a),"('NVS', 100)",,,0.0,75
NCT06079359,Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPP,"Alexion Pharmaceuticals, Inc.",Phase 3,2026-02-27,Hypophosphatasia,"('ALXN', 100)",,,0.0,76
NCT05308446,Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation,National Cancer Institute (NCI),Phase 2,2026-02-28,"Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma, Stage III Colon Cancer AJCC v8","(None, 0)",,,0.0,77
NCT06519526,Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma,Fudan University,Phase 2,2026-02-28,Relapsed/Refractory Peripheral T Cell Lymphoma,"(None, 0)",,,0.0,77
NCT03588754,"Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking?",Yale University,Phase 2,2026-02-28,Alcohol Drinking,"(None, 0)",,,0.0,77
NCT05975983,Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis,InSilico Medicine Hong Kong Limited,Phase 2,2026-02-28,Idiopathic Pulmonary Fibrosis (IPF),"(None, 0)",,,0.0,77
NCT05621616,A Study to Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in the Body of Children Aged 6 Months to Less Than 3 Years of Age With Neurogenic Detrusor Overactivity,"Astellas Pharma Global Development, Inc.",Phase 3,2026-02-28,Neurogenic Detrusor Overactivity,"(None, 0)",,,0.0,77
NCT06697535,A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD),"Guangzhou JOYO Pharma Co., Ltd",Phase 2,2026-02-28,Neuromyelitis Optica Spectrum Disorders,"(None, 0)",,,0.0,77
NCT05967689,A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.,"Taiho Oncology, Inc.",Phase 2,2026-02-28,Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations,"(None, 0)",,,0.0,77
NCT06978192,Clinical Study on the Treatment of Herpes Zoster Pain With Dexmedetomidine Combined With Long-term High Voltage,Fenghui Deng,Phase 2,2026-02-28,Herpes Zoster (HZ),"(None, 0)",,,0.0,77
NCT05316493,Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia,Xiaojun Chen,Phase 3,2026-02-28,"Atypical Endometrial Hyperplasia, Fertility Issues, Overweight and Obesity","(None, 0)",,,0.0,77
NCT06911710,The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors,Tianjin Medical University General Hospital,Phase 2,2026-02-28,"Lymphoma, B-cell, Aggressive Non-Hodgkin (B-NHL), AML (Acute Myelogenous Leukemia), Myeloma Multiple","(None, 0)",,,0.0,77
NCT05468489,To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC,Shanghai Henlius Biotech,Phase 3,2026-02-28,Extensive Stage Small Cell Lung Cancer,"(None, 0)",,,0.0,77
NCT07233291,A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults,Ahmed Ibrahim,Phase 2,2026-02-28,Psoriasis (PsO),"(None, 0)",,,0.0,77
NCT05016245,MANDARIN (S6371),Boston Scientific Corporation,Phase 3,2026-02-28,Inoperable Hepatocellular Carcinoma,"(None, 0)",,,0.0,77
NCT02816021,Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma,M.D. Anderson Cancer Center,Phase 2,2026-02-28,"Melanoma and Other Malignant Neoplasms of Skin, Metastatic Melanoma","(None, 0)",,,0.0,77
NCT06765057,"Effect of Probiotics ""Psychobiotics"" on Depression and Metabolic Syndrome in Saudi Arabia",Roaa Ahmed Alkreadees,Phase 3,2026-02-28,Depression Anxiety Disorder,"(None, 0)",,,0.0,77
NCT03866382,Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors,National Cancer Institute (NCI),Phase 2,2026-02-28,"Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, Bladder Mixed Adenocarcinoma","(None, 0)",,,0.0,77
NCT02481245,BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study,Massachusetts General Hospital,Phase 2,2026-02-28,"Bipolar Disorder, Depressive Episode","(None, 0)",,,0.0,77
NCT05132075,Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer,Novartis Pharmaceuticals,Phase 3,2026-02-28,Non-Small Cell Lung Cancer,"('NVS', 100)",,,0.0,77
NCT04777851,Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7,Translational Research in Oncology,Phase 3,2026-02-28,"Carcinoma, Hepatocellular","(None, 0)",,,0.0,77
NCT05951049,A Study of AT-02 in Subjects With Systemic Amyloidosis.,"Attralus, Inc.",Phase 2,2026-02-28,Amyloidosis; Systemic,"(None, 0)",,,0.0,77
NCT05637203,Study About Group and Phone Follow-Up After a Crisis,University of Rochester,Phase 3,2026-02-28,"Suicide, Crisis; Emotional","('RHHBY', 100)",,,0.0,77
NCT06368141,Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer,Ruijin Hospital,Phase 2,2026-02-28,Colon Cancer,"(None, 0)",,,0.0,77
NCT06582940,Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis,Sun Yat-sen University,Phase 2,2026-03-01,"MRI-guided Adaptive Radiotherapy, Non-small Cell Lung Cancer, Brain Metastasis","(None, 0)",,,0.0,78
NCT06281678,A Study of IBI363 in Subjects with Advanced Solid Malignancies,Innovent Biologics (Suzhou) Co. Ltd.,Phase 2,2026-03-01,"Melanoma, Non-small Cell Lung Cancer, Colorectal Cancer","(None, 0)",,,0.0,78
NCT06678074,"Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI",Implicit Bioscience,Phase 2,2026-03-01,"STEMI, STEMI (ST Elevation MI), STEMI - ST Elevation Myocardial Infarction (MI)","(None, 0)",,,0.0,78
NCT06574880,STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer,"Angela Y. Jia, MD PhD",Phase 2,2026-03-01,"Malignant Neoplasm of Prostate, Locally Advanced Prostate Cancer","(None, 0)",,,0.0,78
NCT05548127,TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A),Pfizer,Phase 2,2026-03-01,Breast Cancer,"('PFE', 100)",,,0.0,78
NCT06063486,"Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms",University of Southern California,Phase 2,2026-03-01,"Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome","(None, 0)",,,0.0,78
NCT05453500,Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia,University of Washington,Phase 2,2026-03-01,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative","(None, 0)",,,0.0,78
NCT06321991,Nodular Shrinking in Dupuytren Disease,Universitaire Ziekenhuizen KU Leuven,Phase 2,2026-03-01,Dupuytren's Disease,"(None, 0)",,,0.0,78
NCT04790474,"Ixazomib-pomalidomide-dexamethasone as Second or Third-line Combination Treatment for Patients With Relapsed and Refractory Multiple Myeloma Previously Treated With Daratumumab, Lenalidomide and Bortezomib",Tel-Aviv Sourasky Medical Center,Phase 2,2026-03-01,"Multiple Myeloma in Relapse, Refractory Multiple Myeloma","(None, 0)",,,0.0,78
NCT05978050,Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma,"Biotech Pharmaceutical Co., Ltd.",Phase 3,2026-03-01,Gastric or Esophagogastric Junction Adenocarcinoma,"(None, 0)",,,0.0,78
NCT03961854,Lactobacillus Johnsonii in Children and Adolescents With T1D,University of Florida,Phase 2,2026-03-01,Type 1 Diabetes (T1D),"(None, 0)",,,0.0,78
NCT07207382,"Clinical and Radiographic Evaluation of Three Biomimetic Materials in Pulp Therapy of Immature Young Permanent Teeth ""A Randomized Controlled Clinical Trial""",Ain Shams University,Phase 3,2026-03-01,Pulpotomy of Young Permanent Molars,"(None, 0)",,,0.0,78
NCT06839118,Safety and Efficacy of Botulinum Toxin A in Patients With Posttraumatic Headache,Danish Headache Center,Phase 3,2026-03-01,Posttraumatic Headache,"(None, 0)",,,0.0,78
NCT04605913,Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC,Mayo Clinic,Phase 2,2026-03-01,"Pancreas Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma","(None, 0)",,,0.0,78
NCT06968000,Double-blind Pilot Study on the Effect of Anionic Exposome Enrichment (Biow) on Recovery and Sleep Quality in Postoperative Patients,Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz,Phase 2,2026-03-01,"Inflammatory Response After Surgery, Postoperative Recovery","(None, 0)",,,0.0,78
NCT05447208,Effect of GH on the Blastocyst Euploid Rate in AMA Patients,ShangHai Ji Ai Genetics & IVF Institute,Phase 3,2026-03-01,"Preimplantation Genetic Testing, Growth Hormone, Age, Parental","(None, 0)",,,0.0,78
NCT04056533,Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy,Instituto de Investigación Marqués de Valdecilla,Phase 2,2026-03-01,CMV,"(None, 0)",,,0.0,78
NCT06289751,Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer,Tongji Hospital,Phase 2,2026-03-01,"Cervical Cancer, Neoadjuvant Chemoimmunotherapy, Radical Hysterectomy","(None, 0)",,,0.0,78
NCT03284385,Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2,National Cancer Institute (NCI),Phase 2,2026-03-01,"Clear Cell Renal Cell Carcinoma, Locally Advanced Clear Cell Renal Cell Carcinoma, Locally Advanced Malignant Solid Neoplasm","(None, 0)",,,0.0,78
NCT03912194,Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation,University of Alabama at Birmingham,Phase 3,2026-03-01,Tobacco Dependence,"(None, 0)",,,0.0,78
NCT05648968,A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia,Novartis Pharmaceuticals,Phase 3,2026-03-02,Warm Autoimmune Hemolytic Anemia (wAIHA),"('NVS', 100)",,,0.0,79
NCT06947330,Comparison Between Erector Spinae Plane Block Versus Serratus Anterior Plane Block Regarding Analgesia Post Modified Radical Mastectomy,Kholoud Usama,Phase 3,2026-03-03,"Modified Radical Mastectomy, Breast Cancer","(None, 0)",,,0.0,80
NCT05277168,"A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS","Jiangsu HengRui Medicine Co., Ltd.",Phase 2,2026-03-03,Advanced Solid Tumors,"(None, 0)",,,0.0,80
NCT06295809,A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007),Merck Sharp & Dohme LLC,Phase 3,2026-03-05,"Carcinoma, Squamous Cell, Skin Neoplasms","('MRK', 100)",,,0.0,82
NCT07084012,A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS,"Shenzhen Wingor Biotechnology Co., Ltd.",Phase 2,2026-03-05,Acute Ischemic Stroke AIS,"(None, 0)",,,0.0,82
NCT06423378,"Bio-Integrative, Fiber-Reinforced Kneebar for Treating Subchondral Insufficiency of the Knee",Vanderbilt University Medical Center,Phase 2,2026-03-05,Subchondral Insufficiency Fracture,"(None, 0)",,,0.0,82
NCT05257629,Aggressive Smoking Cessation Trial (ASAP),Sir Mortimer B. Davis - Jewish General Hospital,Phase 3,2026-03-07,"Acute Coronary Syndrome, Cardiovascular Diseases","(None, 0)",,,0.0,84
NCT06751849,"Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment",The First Affiliated Hospital of Nanchang University,Phase 2,2026-03-10,Advanced NSCLC,"(None, 0)",,,0.0,87
NCT04829539,Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer Treatment,University of Rochester NCORP Research Base,Phase 3,2026-03-11,"Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm","('RHHBY', 100)",,,0.0,88
NCT04225156,A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).,argenx,Phase 3,2026-03-11,Primary Immune Thrombocytopenia,"('ARGX', 80)",,,0.0,88
NCT06233474,Study of Intra-articular Allocetra in Knee Osteoarthritis,Enlivex Therapeutics Ltd.,Phase 2,2026-03-15,"Osteoarthritis, Knee","(None, 0)",,,0.0,92
NCT04455750,A Clinical Study Evaluating the Benefit of Adding Rucaparib to Enzalutamide for Men with Metastatic Prostate Cancer That Has Become Resistant to Testosterone-Deprivation Therapy,Alliance for Clinical Trials in Oncology,Phase 3,2026-03-15,"Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC V8","(None, 0)",,,0.0,92
NCT06116968,An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM,Corxel Pharmaceuticals,Phase 3,2026-03-15,Obstructive Hypertrophic Cardiomyopathy,"('OLMA', 81)",,,0.0,92
NCT06781996,A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer,"Gustave Roussy, Cancer Campus, Grand Paris",Phase 3,2026-03-15,"Breast Cancer, Breast Cancer Early Stage Breast Cancer (Stage 1-3)","(None, 0)",,,0.0,92
NCT00585507,Efficacy and Safety of 500mg of Fulvestrant,Beth Israel Deaconess Medical Center,Phase 2,2026-03-15,Breast Cancer,"(None, 0)",,,0.0,92
NCT05012254,Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases,Fundación GECP,Phase 2,2026-03-15,"Non Small Cell Lung Cancer, Brain Metastases, Adult, Lung Cancer","(None, 0)",,,0.0,92
NCT03997123,Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC,AstraZeneca,Phase 3,2026-03-16,Triple Negative Breast Neoplasms,"('AZN', 100)",,,0.0,93
NCT05875168,First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors,Daiichi Sankyo,Phase 2,2026-03-17,"Advanced Solid Tumor, Metastatic Solid Tumor","(None, 0)",,,0.0,94
NCT06301412,Combination of Hypothermia and Thrombectomy in Acute Stroke,University of Freiburg,Phase 3,2026-03-18,"Ischemic Stroke, Large Vessel Occlusion, Endovascular Treatment","(None, 0)",,,0.0,95
NCT06312020,A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome,Amgen,Phase 2,2026-03-19,Sjogren's Syndrome,"('AMGN', 100)",,,0.0,96
NCT06767761,A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2DM) Treated With Basal + Prandial Insulin,Gan & Lee Pharmaceuticals.,Phase 3,2026-03-19,Diabetes,"('OLMA', 83)",,,0.0,96
NCT02399371,Pembrolizumab in Treating Patients With Malignant Mesothelioma,University of Chicago,Phase 2,2026-03-20,"Biphasic Mesothelioma, Epithelioid Mesothelioma, Peritoneal Malignant Mesothelioma","(None, 0)",,,0.0,97
NCT06321289,Allogeneic TRAC Locus-inserted CD19-targeting STAR T Cell Therapy in r/r B-NHL,Chinese PLA General Hospital,Phase 2,2026-03-20,"Non-hodgkin Lymphoma,B Cell","(None, 0)",,,0.0,97
NCT05818553,A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE),Praxis Precision Medicines,Phase 3,2026-03-23,"SCN2A Encephalopathy, SCN8A Encephalopathy","('PRAX', 93)",,,0.0,100
NCT06362694,Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on Anti-BRAF Therapy,"Saint Petersburg State University, Russia",Phase 2,2026-03-25,Anaplastic Thyroid Cancer,"(None, 0)",,,0.0,102
NCT04498117,Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery,CanariaBio Inc.,Phase 3,2026-03-26,"Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer","(None, 0)",,,0.0,103
NCT05180474,GEN1047 for Solid Tumors - First in Human (FIH) Trial,Genmab,Phase 2,2026-03-26,"Breast Cancer, Breast Neoplasms, Endometrial Cancer, Endometrial Neoplasm, Ovarian Cancer, Ovarian Neoplasms","(None, 0)",,,0.0,103
NCT06768671,"An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)",MoonLake Immunotherapeutics AG,Phase 3,2026-03-27,Hidradenitis Suppurativa,"(None, 0)",,,0.0,104
NCT04895696,A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE),Bristol-Myers Squibb,Phase 2,2026-03-29,Systemic Lupus Erythematosus,"('BMY', 100)",,,0.0,106
NCT04943211,"Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging",Anna Raciborska,Phase 3,2026-03-30,Histiocytosis,"(None, 0)",,,0.0,107
NCT03609580,Post-operative Urinary Retention (POUR) Following Thoracic Surgery,Hackensack Meridian Health,Phase 2,2026-03-30,Urinary Retention,"(None, 0)",,,0.0,107
NCT05472337,Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome,Pontificia Universidad Catolica de Chile,Phase 2,2026-03-30,Acute Coronary Syndrome,"(None, 0)",,,0.0,107
NCT05751187,Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients,Shanghai Chest Hospital,Phase 2,2026-03-30,Non-squamous NSCLC,"(None, 0)",,,0.0,107
NCT05976243,"A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines",Novartis Pharmaceuticals,Phase 3,2026-03-30,Chronic Inducible Urticaria,"('NVS', 100)",,,0.0,107
NCT05543681,Clinical Trial on Agitation in Alzheimer's Dementia,"IGC Pharma, LLC",Phase 2,2026-03-30,"Alzheimer Disease, Agitation,Psychomotor, Care Giving Burden","(None, 0)",,,0.0,107
NCT05316935,GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients,Xiaojun Chen,Phase 3,2026-03-30,"Endometrial Neoplasms, Atypical Endometrial Hyperplasia, Progesterone Resistance","(None, 0)",,,0.0,107
NCT03175224,APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors,Apollomics Inc.,Phase 2,2026-03-30,"Solid Tumors, Advanced Cancer, Renal Cancer","(None, 0)",,,0.0,107
NCT06235086,A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus,"CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.",Phase 3,2026-03-30,Type 2 Diabetes Mellitus,"(None, 0)",,,0.0,107
NCT06769659,A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures,"NeuroPro Therapeutics, Inc.",Phase 2,2026-03-30,"Epilepsy, Generalized, Epilepsy, Absence","('NRIX', 85)",,,0.0,107
NCT05601973,"Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI",ETOP IBCSG Partners Foundation,Phase 2,2026-03-30,Non Small Cell Lung Cancer,"(None, 0)",,,0.0,107
NCT07191067,Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty,"Synaptrix, Inc.",Phase 3,2026-03-30,Pain,"(None, 0)",,,0.0,107
NCT06199921,ATORvastatin in Pulmonary TUBerculosis,Obafemi Awolowo University Teaching Hospital,Phase 2,2026-03-30,"Pulmonary Tuberculosis, Tuberculosis, Koch's Disease","(None, 0)",,,0.0,107
NCT05442710,Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy,Artcline GmbH,Phase 2,2026-03-30,"Sepsis, Severe","(None, 0)",,,0.0,107
NCT05211986,Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.,"Immunis, Inc.",Phase 2,2026-03-30,Muscle Atrophy,"('IMUX', 91)",,,0.0,107
NCT03836950,rTMS to Improve Cognition in Parkinson's,VA Office of Research and Development,Phase 2,2026-03-31,"Parkinson's Disease, Mild Cognitive Impairment","(None, 0)",,,0.0,108
NCT06468956,Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis,"Guangdong Hengrui Pharmaceutical Co., Ltd",Phase 3,2026-03-31,Moderate to Severe Atopic Dermatitis,"(None, 0)",,,0.0,108
NCT04787744,Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer,VA Office of Research and Development,Phase 3,2026-03-31,"Prostate Cancer, Oligometastasis, Oligorecurrence","(None, 0)",,,0.0,108
NCT06797297,A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy,Innovent Biologics (Suzhou) Co. Ltd.,Phase 2,2026-03-31,Melanoma,"(None, 0)",,,0.0,108
NCT06189495,"A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease","Changchun GeneScience Pharmaceutical Co., Ltd.",Phase 2,2026-03-31,"Systemic Sclerosis Associated Interstitial Lung Disease, Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD), Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)","(None, 0)",,,0.0,108
NCT06799234,Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003),University of Oxford,Phase 2,2026-03-31,Rift Valley Fever,"(None, 0)",,,0.0,108
NCT05755997,CERebrolysin In CADASIL,Ever Neuro Pharma GmbH,Phase 2,2026-03-31,Cadasil,"(None, 0)",,,0.0,108
NCT04791579,Antibiotic Prophylaxis for Neurogenic Bladder Botox,University of Alberta,Phase 2,2026-03-31,"Neurogenic Bladder, Post-operative Urinary Tract Infections","(None, 0)",,,0.0,108
NCT02629809,"Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia",M.D. Anderson Cancer Center,Phase 2,2026-03-31,"Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma","(None, 0)",,,0.0,108
NCT05939661,A Multicenter Single-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal Cancer,Osaka University,Phase 2,2026-03-31,Rectal Cancer,"(None, 0)",,,0.0,108
NCT06915246,A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma,VIVUS LLC,Phase 2,2026-03-31,"Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma","(None, 0)",,,0.0,108
NCT04417660,Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma,National Cancer Institute (NCI),Phase 2,2026-03-31,"Thymic Epithelial Tumor, Recurrent Thymoma, Thymic Cancer","(None, 0)",,,0.0,108
NCT05198323,A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT,"Lumosa Therapeutics Co., Ltd.",Phase 2,2026-03-31,Acute Ischemic Stroke,"(None, 0)",,,0.0,108
NCT05863234,Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia,Hiroshima University Hospital,Phase 2,2026-03-31,Aggressive NK Cell Leukemia,"(None, 0)",,,0.0,108
NCT06913725,An Exploratory Study to Evaluate the Efficacy and Safety of FCN-159 in Patients With Brain Arteriovenous Malformations,"Xuanwu Hospital, Beijing",Phase 2,2026-03-31,Brain Arteriovenous Malformations,"(None, 0)",,,0.0,108
NCT05346354,Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD,"Alexion Pharmaceuticals, Inc.",Phase 3,2026-03-31,Neuromyelitis Optica Spectrum Disorder,"('ALXN', 100)",,,0.0,108
NCT05498181,Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation,Brigham and Women's Hospital,Phase 2,2026-03-31,Hemodialysis,"(None, 0)",,,0.0,108
NCT05211323,"A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer",National Cancer Institute (NCI),Phase 2,2026-03-31,"Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Stage III Liver Cancer, Stage IV Liver Cancer","(None, 0)",,,0.0,108
NCT06774131,A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer,UroGen Pharma Ltd.,Phase 3,2026-03-31,"Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma","(None, 0)",,,0.0,108
NCT05579639,Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant,"Children's Hospital Medical Center, Cincinnati",Phase 2,2026-03-31,Allogeneic Stem Cell Transplantation,"(None, 0)",,,0.0,108
NCT05237388,Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease,Duke University,Phase 2,2026-03-31,Chronic Kidney Diseases,"(None, 0)",,,0.0,108
NCT04027647,Phase 2 Study of Dacomitinib in NSCLC,"National Cancer Centre, Singapore",Phase 2,2026-03-31,"NSCLC Stage IIIB, NSCLC Stage IIIC, NSCLC Stage IV","(None, 0)",,,0.0,108
NCT04619862,Efficacy of Gabapentin in Treating Pain in Children With SNI (Gabapentin Trial),University of British Columbia,Phase 2,2026-03-31,"Pain, Neuropathic Pain, Irritability","(None, 0)",,,0.0,108
NCT03310879,Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6,Dana-Farber Cancer Institute,Phase 2,2026-04-01,Cancer,"(None, 0)",,,0.0,109
NCT07136077,A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy,M.D. Anderson Cancer Center,Phase 2,2026-04-01,"Minimal Residual Disease, Adjuvant Chemotherapy, Colorectal Cancer","(None, 0)",,,0.0,109
NCT06316427,Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies,Beijing GoBroad Hospital,Phase 2,2026-04-01,"T-cell Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia","(None, 0)",,,0.0,109
NCT06122662,AMX0035 and Progressive Supranuclear Palsy,Amylyx Pharmaceuticals Inc.,Phase 3,2026-04-01,"Progressive Supranuclear Palsy, PSP, Neurodegenerative Diseases","('ALNY', 87)",,,0.0,109
NCT06305793,"RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)",Kanecia Obie Zimmerman,Phase 2,2026-04-01,"Long COVID, Long Coronavirus Disease 2019 (Covid19), Long Covid-19","(None, 0)",,,0.0,109
NCT02991469,A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS),Sanofi,Phase 2,2026-04-01,Juvenile Idiopathic Arthritis,"('SNY', 100)",,,0.0,109
NCT06625398,"An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)","Viridian Therapeutics, Inc.",Phase 3,2026-04-01,Thyroid Eye Disease,"('VKTX', 88)",,,0.0,109
NCT05778591,Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia,"University of California, Los Angeles",Phase 2,2026-04-01,Schizophrenia,"(None, 0)",,,0.0,109
NCT06925464,CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas,Beijing GoBroad Hospital,Phase 2,2026-04-01,"T-Cell Non-Hodgkin Lymphoma, T-cell Lymphoma (PTCL and CTCL)","(None, 0)",,,0.0,109
NCT07132177,Targeted Naltrexone to Support Individuals Participating in Dry January,Brigham and Women's Hospital,Phase 2,2026-04-01,Alcohol Misuse,"(None, 0)",,,0.0,109
NCT06365879,To Compare Efficacy and Safety of CMAB007 and Xolair® in Patients With Chronic Spontaneous Urticaria,"Taizhou Mabtech Pharmaceutical Co.,Ltd",Phase 3,2026-04-01,Chronic Spontaneous Urticaria,"(None, 0)",,,0.0,109
NCT05817903,Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients,Consorzio Oncotech,Phase 2,2026-04-01,Metastatic Renal Cell Carcinoma,"(None, 0)",,,0.0,109
NCT06939816,Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis),Enyo Pharma,Phase 2,2026-04-01,"Chronic Kidney Disease Stage 2, Chronic Kidney Disease Stage 3, Metabolic Dysfunction-Associated Steatohepatitis","(None, 0)",,,0.0,109
NCT04812366,Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer,University of British Columbia,Phase 2,2026-04-01,Prostate Cancer,"(None, 0)",,,0.0,109
NCT06342037,NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial,The Netherlands Cancer Institute,Phase 2,2026-04-01,Metastatic Breast Cancer,"(None, 0)",,,0.0,109
NCT06034938,DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road),"University Hospital, Caen",Phase 2,2026-04-01,Hiv,"(None, 0)",,,0.0,109
NCT05331937,TMS for Exposure Therapy Resistant OCD,"Amsterdam UMC, location VUmc",Phase 3,2026-04-01,"1 Hz Real rTMS to the Pre-SMA, 1 Hz Sham rTMS to the Pre-SMA","(None, 0)",,,0.0,109
NCT06926842,Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2),Zealand Pharma,Phase 2,2026-04-02,"Overweight, Type 2 Diabetes, Obesity","(None, 0)",,,0.0,110
NCT05677451,"24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up",Novartis Pharmaceuticals,Phase 3,2026-04-02,Chronic Spontaneous Urticaria,"('NVS', 100)",,,0.0,110
NCT06693908,"A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis","Genentech, Inc.",Phase 2,2026-04-03,Moderate to Severe Ulcerative Colitis,"('RHHBY', 100)",,,0.0,111
NCT03107416,Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells,Memorial Sloan Kettering Cancer Center,Phase 2,2026-04-05,Unresectable Hepatocellular Carcinoma,"(None, 0)",,,0.0,113
NCT05773820,A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors,"Wigen Biomedicine Technology (Shanghai) Co., Ltd.",Phase 2,2026-04-08,Advanced Solid Tumors,"(None, 0)",,,0.0,116
NCT05217446,A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer,Pfizer,Phase 2,2026-04-12,Metastatic Colorectal Cancer,"('PFE', 100)",,,0.0,120
NCT05664191,Levosimendan as Treatment of Aneurysmal SubArachnoid Haemorrhage,Assistance Publique - Hôpitaux de Paris,Phase 2,2026-04-13,Sub-arachnoid Haemorrhage,"(None, 0)",,,0.0,121
NCT05992935,"Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age","ModernaTX, Inc.",Phase 2,2026-04-14,Norovirus Acute Gastroenteritis,"('MRNA', 100)",,,0.0,122
NCT04829708,Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy,Shandong Cancer Hospital and Institute,Phase 3,2026-04-15,Limited Stage Small Cell Lung Cancer,"(None, 0)",,,0.0,123
NCT04831684,Novel MGluR5 Modulator Effects on Alcohol Drinking and MRI Outcomes,Medical University of South Carolina,Phase 2,2026-04-15,Alcohol Use Disorder,"(None, 0)",,,0.0,123
NCT06609005,"A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer","Shenzhen Ionova Life Sciences Co., Ltd.",Phase 2,2026-04-17,Advanced Metastatic Castration Resistant Prostate Cancer,"(None, 0)",,,0.0,125
NCT04292054,Antibioprophylaxis for Excision-graft Surgery in Burn Patient (A2B-TRIAL),Assistance Publique - Hôpitaux de Paris,Phase 3,2026-04-18,Burns Surgery,"(None, 0)",,,0.0,126
NCT05718869,"Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL Study",City of Hope Medical Center,Phase 2,2026-04-19,"Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma","(None, 0)",,,0.0,127
NCT06364384,Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma,"Sixth Affiliated Hospital, Sun Yat-sen University",Phase 2,2026-04-20,Rectal Squamous Cell Carcinoma,"(None, 0)",,,0.0,128
NCT04305054,Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02),Merck Sharp & Dohme LLC,Phase 2,2026-04-20,Melanoma,"('MRK', 100)",,,0.0,128
NCT06406634,Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma,Hunan Cancer Hospital,Phase 2,2026-04-20,Hepatocellular Carcinoma,"(None, 0)",,,0.0,128
NCT06970145,Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma,"Nanfang Hospital, Southern Medical University",Phase 2,2026-04-20,Craniopharyngiomas,"(None, 0)",,,0.0,128
NCT05135559,A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors,Novo Nordisk A/S,Phase 3,2026-04-21,Haemophilia A and B With and Without Inhibitors,"(None, 0)",,,0.0,129
NCT04696809,A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma,Janssen Pharmaceutical K.K.,Phase 2,2026-04-22,Hematologic Malignancies,"(None, 0)",,,0.0,130
NCT06398405,A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer,Shandong Cancer Hospital and Institute,Phase 2,2026-04-22,"Esophageal Cancer, Dysphagia, Esophageal, Epigallocatechin Gallate","(None, 0)",,,0.0,130
NCT06600789,A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies,Carrick Therapeutics Limited,Phase 2,2026-04-22,Solid Malignancies,"(None, 0)",,,0.0,130
NCT05367089,The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms,Maastricht University Medical Center,Phase 3,2026-04-22,"Candidiasis, Vulvovaginal, Recurrent Candidiasis of Vagina","(None, 0)",,,0.0,130
NCT07081958,A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity,Hoffmann-La Roche,Phase 2,2026-04-23,Obesity or Overweight,"('RHHBY', 100)",,,0.0,131
NCT06750302,"Effectiveness of Penthrox vs Placebo in Sinus Procedures, a Clinical Trial","St. Paul's Hospital, Canada",Phase 2,2026-04-24,Chronic Rhinosinusitis (CRS),"(None, 0)",,,0.0,132
NCT06284434,Liposomal Bupivacaine Use in Alveolar Bone Graft Patients,Kerry O'Rourke,Phase 3,2026-04-24,Cleft Lip and Palate,"(None, 0)",,,0.0,132
NCT05827835,CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases,Zhejiang University,Phase 2,2026-04-25,"Hematologic Diseases, Neoplasms","(None, 0)",,,0.0,133
NCT05354557,Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT),Memorial Sloan Kettering Cancer Center,Phase 2,2026-04-26,Multiple Myeloma,"(None, 0)",,,0.0,134
NCT05488873,A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy,"WinSanTor, Inc",Phase 2,2026-04-26,Chemotherapy-induced Peripheral Neuropathy,"(None, 0)",,,0.0,134
NCT06944106,A Study on Ivonescimab Plus Chemotherapy as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer,Tianjin Medical University Cancer Institute and Hospital,Phase 2,2026-04-28,Pancreatic Cancer,"(None, 0)",,,0.0,136
NCT05715229,Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy,Hackensack Meridian Health,Phase 2,2026-04-28,"Carcinoma, Non-Small-Cell Lung","(None, 0)",,,0.0,136
NCT06223958,Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration,"Ocular Therapeutix, Inc.",Phase 3,2026-04-29,Neovascular Age-Related Macular Degeneration,"(None, 0)",,,0.0,137
NCT06125522,TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C),Pfizer,Phase 2,2026-04-30,Breast Cancer,"('PFE', 100)",,,0.0,138
NCT06367088,Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Phase 2,2026-04-30,"Triple-negative Breast Cancer, Cadonilimab","(None, 0)",,,0.0,138
NCT05153317,Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and Older,Vertex Pharmaceuticals Incorporated,Phase 3,2026-04-30,Cystic Fibrosis,"('VRTX', 100)",,,0.0,138
NCT04071236,Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy,National Cancer Institute (NCI),Phase 2,2026-04-30,"Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lymph Nodes","(None, 0)",,,0.0,138
NCT04906395,Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer,Tolmar Inc.,Phase 3,2026-04-30,Breast Cancer,"(None, 0)",,,0.0,138
NCT04494412,An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection,GlaxoSmithKline,Phase 2,2026-04-30,"Influenza, Human, Arthralgia","(None, 0)",,,0.0,138
NCT04469959,Dopaminergic Dysfunction in Late-Life Depression,Vanderbilt University Medical Center,Phase 2,2026-04-30,"Late Life Depression, Cognitive Decline, Depressive Disorder, Treatment-Resistant","(None, 0)",,,0.0,138
NCT05543330,A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC,"Wuhan YZY Biopharma Co., Ltd.",Phase 2,2026-04-30,"Malignant Pleural Effusions, NSCLC Stage IV","(None, 0)",,,0.0,138
NCT06182085,Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD),PRInnovation GmbH,Phase 2,2026-04-30,"Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease, Early Onset","(None, 0)",,,0.0,138
NCT05270668,Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007),"Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)",Phase 2,2026-04-30,"Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease","('MRK', 100)",,,0.0,138
NCT04098666,Metformin in Alzheimer's Dementia Prevention,Columbia University,Phase 3,2026-04-30,Mild Cognitive Impairment,"(None, 0)",,,0.0,138
NCT05179226,Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia,Pharmacosmos A/S,Phase 3,2026-04-30,"Iron Deficiency, Anaemia in Children","(None, 0)",,,0.0,138
NCT06937749,A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH),Innovent Biologics (Suzhou) Co. Ltd.,Phase 2,2026-04-30,Metabolic Dysfunction-associated Steatohepatitis (MASH),"(None, 0)",,,0.0,138
NCT06082635,TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC),"Shenzhen TargetRx, Inc.",Phase 3,2026-04-30,Non Small Cell Lung Cancer,"(None, 0)",,,0.0,138
NCT03317392,Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis,National Cancer Institute (NCI),Phase 2,2026-04-30,"Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8","(None, 0)",,,0.0,138
NCT05156281,Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS),Novartis Pharmaceuticals,Phase 3,2026-04-30,Relapsing Multiple Sclerosis,"('NVS', 100)",,,0.0,138
NCT04659811,Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma,"Nancy Ann Oberheim Bush, MD",Phase 2,2026-04-30,"Grade I Meningioma, Adult, Grade II Meningioma, Adult, Grade III Meningioma, Adult","(None, 0)",,,0.0,138
NCT04542161,Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome,Weill Medical College of Cornell University,Phase 2,2026-04-30,"Chronic Fatigue Syndrome, Myalgic Encephalomyelitis","(None, 0)",,,0.0,138
NCT05970510,A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.,Luye Pharma Group Ltd.,Phase 3,2026-04-30,Generalized Anxiety Disorder,"(None, 0)",,,0.0,138
NCT04813276,Efficacy of a Self-advocacy Serious Game Intervention,University of Pittsburgh,Phase 3,2026-04-30,"Self-Management, Quality of Life","(None, 0)",,,0.0,138
NCT07007949,a New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia,The First Affiliated Hospital of Soochow University,Phase 2,2026-04-30,"Acute Myeloid Leukemia, IDH1 Gene Mutation, Ivosidenib","(None, 0)",,,0.0,138
NCT06189742,Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS),Dr. Anne Ellis,Phase 2,2026-04-30,Asthma With Allergic Rhinitis,"(None, 0)",,,0.0,138
NCT05231837,Neighborhood Park Youth Sports Program Fee Waiver and Intensive Family Outreach,University of Minnesota,Phase 3,2026-04-30,Physical Activity,"(None, 0)",,,0.0,138
NCT04944979,"Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)",Kedrion S.p.A.,Phase 3,2026-04-30,Primary Immunodeficiency Disease,"(None, 0)",,,0.0,138
NCT05872685,Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05),Yu jiren,Phase 2,2026-04-30,"Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Proficient Mismatch Repair","(None, 0)",,,0.0,138
NCT06602193,Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD),Denali Therapeutics Inc.,Phase 2,2026-04-30,Parkinson Disease,"('DNLI', 100)",,,0.0,138
NCT07154342,A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis,"Genrix (Shanghai) Biopharmaceutical Co., Ltd.",Phase 3,2026-04-30,"Allergic Rhinitis, Seasonal","(None, 0)",,,0.0,138
NCT06589778,A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer,"Shanghai Hengrui Pharmaceutical Co., Ltd.",Phase 2,2026-04-30,Non-Small Cell Lung Cancer,"(None, 0)",,,0.0,138
NCT06911684,"Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC.",Sun Yat-sen University,Phase 2,2026-04-30,Rectal Cancer Patients,"(None, 0)",,,0.0,138
NCT05147220,Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS),Novartis Pharmaceuticals,Phase 3,2026-04-30,Relapsing Multiple Sclerosis,"('NVS', 100)",,,0.0,138
NCT06897748,A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated Eosinophils,AstraZeneca,Phase 2,2026-04-30,Chronic Obstructive Pulmonary Disease (COPD),"('AZN', 100)",,,0.0,138
NCT04699604,A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3),Bridgette Jones,Phase 3,2026-05-01,Allergic Asthma,"(None, 0)",,,0.0,139
NCT02834013,Nivolumab and Ipilimumab in Treating Patients With Rare Tumors,National Cancer Institute (NCI),Phase 2,2026-05-01,"Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma","(None, 0)",,,0.0,139
NCT03917082,Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer,British Columbia Cancer Agency,Phase 2,2026-05-01,"Breast Cancer Female, Hormone Receptor Positive Tumor","(None, 0)",,,0.0,139
NCT07152639,Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above,"Chengdu CoenBiotech Co., Ltd",Phase 3,2026-05-01,Tuberculosis,"(None, 0)",,,0.0,139
NCT05540834,Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure,South West Sydney Local Health District,Phase 2,2026-05-01,"Acute Respiratory Failure, Hypercoagulability, Fibrinolysis Shutdown","(None, 0)",,,0.0,139
NCT06951074,Insulin Producing Stem Cell Transplantation Clinical Trial in Type 1 Diabetes,Ain Shams University,Phase 3,2026-05-01,"Stem Cells, Type 1 Diabetes","(None, 0)",,,0.0,139
NCT07182526,Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycystic Ovary Syndrome,Al-Mustansiriyah University,Phase 2,2026-05-01,PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries,"(None, 0)",,,0.0,139
NCT06510361,Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy,Beth Israel Deaconess Medical Center,Phase 2,2026-05-01,"Lymphoma, Follicular Lymphoma, Lymphoma,Non-Hodgkin","(None, 0)",,,0.0,139
NCT06924619,Neoadjuvant Radiotherapy for Locally Advanced Unresectable Thymoma,"Second Affiliated Hospital, School of Medicine, Zhejiang University",Phase 2,2026-05-01,Locally Advanced Thymoma,"(None, 0)",,,0.0,139
NCT04274179,Ketogenic Diet for New-Onset Absence Epilepsy,Johns Hopkins University,Phase 3,2026-05-01,"Absence Epilepsy, Ketogenic Dieting, Epilepsy, Absence","(None, 0)",,,0.0,139
NCT06341400,RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients,Zhujiang Hospital,Phase 2,2026-05-01,"Bladder Cancer, Muscle-Invasive Bladder Carcinoma","(None, 0)",,,0.0,139
NCT06397131,A Study to Determine the Safety and Efficacy of NT-501 With MHFM,Neurotech Pharmaceuticals,Phase 3,2026-05-01,Macular Telangiectasia Type 2,"(None, 0)",,,0.0,139
NCT06683885,"A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma",Mingzhi Zhang,Phase 2,2026-05-01,Newly Diagnosed Diffuse Large B-cell Lymphoma,"(None, 0)",,,0.0,139
NCT04878094,A Study of Intra-operative Imaging in Women With Ovarian Cancer,Memorial Sloan Kettering Cancer Center,Phase 3,2026-05-03,"Ovarian Cancer, Ovarian Carcinoma","(None, 0)",,,0.0,141
NCT06327321,Vitiligo Treatment by Targeting TYK2 Mediated Responses,Centre Hospitalier Universitaire de Nice,Phase 2,2026-05-05,"Vitiligo, Generalized","(None, 0)",,,0.0,143
NCT07212426,"Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.",Longbio Pharma,Phase 2,2026-05-06,PNH - Paroxysmal Nocturnal Hemoglobinuria,"(None, 0)",,,0.0,144
NCT03288545,A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer,"Astellas Pharma Global Development, Inc.",Phase 2,2026-05-11,"Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Urologic Neoplasms","(None, 0)",,,0.0,149
NCT05629416,The Communicate Study Partnership,Menzies School of Health Research,Phase 2,2026-05-11,"Aboriginal Health, Cultural Safety, Access to Interpreters","(None, 0)",,,0.0,149
NCT06702995,Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate Cancer,Evopoint Biosciences Inc.,Phase 2,2026-05-13,"Metastatic Castrate-Resistant Prostate Cancer, mCRPC (Metastatic Castration-resistant Prostate Cancer)","(None, 0)",,,0.0,151
NCT05382442,A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer,Akeso,Phase 2,2026-05-15,Metastatic Colorectal Cancer,"(None, 0)",,,0.0,153
NCT06416228,Beetroot Juice NO Cold Study,Southern Methodist University,Phase 2,2026-05-15,"Respiratory Tract Infections, Cold Symptoms, Exhaled Nitric Oxide","(None, 0)",,,0.0,153
NCT05133882,A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML,"Sunshine Lake Pharma Co., Ltd.",Phase 2,2026-05-15,"Acute Myeloid Leukemia, Adult","(None, 0)",,,0.0,153
NCT06810726,"Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.","Estar Medical dba Medical Technologies, LTD",Phase 2,2026-05-15,"Diabetic Foot Ulcer, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus (T2DM)","(None, 0)",,,0.0,153
NCT06969807,Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease,Chinese PLA General Hospital,Phase 2,2026-05-15,Diabetic Kidney Disease (DKD),"(None, 0)",,,0.0,153
NCT05999240,Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder,New York State Psychiatric Institute,Phase 2,2026-05-15,Autism Spectrum Disorder,"(None, 0)",,,0.0,153
NCT04452032,Prospective Pilot Study Evaluating Dental Side Effects of Radiotherapy on Subjects Treated for Head and Neck Cancer,Jules Bordet Institute,Phase 2,2026-05-16,Head and Neck Squamous Cell Carcinoma,"(None, 0)",,,0.0,154
NCT06415669,A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma,The First Affiliated Hospital of Xiamen University,Phase 2,2026-05-19,Gastric/Gastroesophageal Junction Adenocarcinoma,"(None, 0)",,,0.0,157
NCT05049057,Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI,Henry M. Jackson Foundation for the Advancement of Military Medicine,Phase 2,2026-05-19,"Posttraumatic Headache, Mild Traumatic Brain Injury","(None, 0)",,,0.0,157
NCT04938817,Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98),Merck Sharp & Dohme LLC,Phase 2,2026-05-20,Small Cell Lung Carcinoma,"('MRK', 100)",,,0.0,158
NCT05036226,COAST Therapy in Advanced Solid Tumors and Prostate Cancer,Medical University of South Carolina,Phase 2,2026-05-21,"Prostate Cancer Recurrent, Solid Tumor, Adult","(None, 0)",,,0.0,159
NCT05866432,Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases,Medical University of Vienna,Phase 2,2026-05-23,Breast Cancer Stage IV,"(None, 0)",,,0.0,161
NCT06182124,A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults,Pfizer,Phase 2,2026-05-23,Pneumococcal Disease,"('PFE', 100)",,,0.0,161
NCT04009499,"A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis",UCB Biopharma SRL,Phase 3,2026-05-25,Psoriatic Arthritis,"(None, 0)",,,0.0,163
NCT04458610,Zanubrutinib and Rituximab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma,M.D. Anderson Cancer Center,Phase 2,2026-05-26,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,"(None, 0)",,,0.0,164
NCT07054034,Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects,Shanghai Mabgeek Biotech.Co.Ltd,Phase 2,2026-05-26,Bronchial Asthma,"(None, 0)",,,0.0,164
NCT02094794,Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML,City of Hope Medical Center,Phase 2,2026-05-26,"Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)","(None, 0)",,,0.0,164
NCT06252285,"Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers","Sanofi Pasteur, a Sanofi Company",Phase 3,2026-05-27,RSV Immunisation,"('SNY', 100)",,,0.0,165
NCT04916249,Testing an Herbal Pain Relief Patch to Reduce Pain in Cancer Survivors,Memorial Sloan Kettering Cancer Center,Phase 2,2026-05-28,"Cancer, Remission","(None, 0)",,,0.0,166
NCT04055649,ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer,Ira Winer,Phase 2,2026-05-28,"Malignant Ovarian Epithelial Tumor, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma","(None, 0)",,,0.0,166
NCT03701334,A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer,Novartis Pharmaceuticals,Phase 3,2026-05-29,Early Breast Cancer,"('NVS', 100)",,,0.0,167
NCT07207408,"Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age",Dynavax Technologies Corporation,Phase 2,2026-05-29,Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis,"('DGXA', 100)",,,0.0,167
NCT03847428,Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment,AstraZeneca,Phase 3,2026-05-29,Hepatocellular Carcinoma,"('AZN', 100)",,,0.0,167
NCT05591677,D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression (COGENT),The Alfred,Phase 2,2026-05-29,Major Depressive Disorder,"(None, 0)",,,0.0,167
NCT04669171,"A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma",Enterome,Phase 2,2026-05-30,"Follicular Lymphoma, Marginal Zone Lymphoma","(None, 0)",,,0.0,168
NCT02710253,Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy,M.D. Anderson Cancer Center,Phase 2,2026-05-30,"Hematopoietic and Lymphoid Cell Neoplasm, Metastatic Malignant Solid Neoplasm","(None, 0)",,,0.0,168
NCT05211232,Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma,Sun Yat-sen University,Phase 3,2026-05-30,Nasopharyngeal Carcinoma,"(None, 0)",,,0.0,168
NCT05221645,Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma,University of Southampton,Phase 2,2026-05-30,Diffuse Large B Cell Lymphoma,"(None, 0)",,,0.0,168
NCT06509009,Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma,"Cancer Institute and Hospital, Chinese Academy of Medical Sciences",Phase 2,2026-05-30,Nasopharyngeal Carcinoma by AJCC V8 Stage,"(None, 0)",,,0.0,168
NCT06126783,"A Multicenter, Open-label Extension Study Evaluating the Efficacy and Safety of IBI311 in Subjects With Thyroid Eye Disease",Innovent Biologics (Suzhou) Co. Ltd.,Phase 3,2026-05-30,"Thyroid Eye Disease, TED","(None, 0)",,,0.0,168
NCT04335656,Reducing Innate Inflammation in New Onset Type 1 Diabetes,Medical College of Wisconsin,Phase 2,2026-05-31,"Type 1 Diabetes, type1diabetes, Type 1 Diabetes Mellitus","(None, 0)",,,0.0,169
NCT06797401,Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia,Ribocure Pharmaceuticals AB,Phase 2,2026-05-31,Dyslipidemias,"(None, 0)",,,0.0,169
NCT04084080,Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE),University of Pittsburgh,Phase 3,2026-05-31,Sickle Cell Disease,"(None, 0)",,,0.0,169
NCT04782687,Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma,US Oncology Research,Phase 2,2026-05-31,"Multiple Myeloma, Myeloma Multiple, Kahler Disease","(None, 0)",,,0.0,169
NCT04817007,A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis),Bristol-Myers Squibb,Phase 2,2026-05-31,Myelofibrosis,"('BMY', 100)",,,0.0,169
NCT06987643,A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke,EIP Pharma Inc,Phase 2,2026-05-31,"Moderate to Severe Acute Ischaemic Stroke, Ischaemic Stroke","(None, 0)",,,0.0,169
NCT06347718,CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease,Miltenyi Biomedicine GmbH,Phase 2,2026-05-31,"Systemic Lupus Erythematosus, Systemic Sclerosis, Dermatomyositis","(None, 0)",,,0.0,169
NCT05339126,RNS System LGS Feasibility Study,NeuroPace,Phase 2,2026-05-31,"Epilepsy, Lennox Gastaut Syndrome, Lennox-Gastaut Syndrome, Intractable","(None, 0)",,,0.0,169
NCT07008885,BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B-ALL,Chinese PLA General Hospital,Phase 2,2026-05-31,Acute Lymphocytic Leukemia,"(None, 0)",,,0.0,169
NCT03616782,Ixazomib Maintenance in Patients With Newly Diagnosed Mantle Cell Lymphoma(MCL),Ho Sup Lee,Phase 2,2026-05-31,Mantle Cell Lymphoma,"(None, 0)",,,0.0,169
NCT05641623,OSU6162 as add-on in SSRI/SNRI-resistant Depression,Göteborg University,Phase 2,2026-05-31,"Depression, Depressive Disorder, Treatment-Resistant, Depressive Disorder","(None, 0)",,,0.0,169
NCT04567355,Migraine Manager (R01),"Children's Hospital Medical Center, Cincinnati",Phase 2,2026-05-31,"Migraine, Migraine Disorders","(None, 0)",,,0.0,169
NCT06747312,Effect of Belimumab on Antibody Titers in Primary APS Patients,Ruijin Hospital,Phase 2,2026-05-31,Antiphospholipid Syndrome (APS),"(None, 0)",,,0.0,169
NCT04932577,Faecal Microbiota Transplantation for Liver Cirrhosis,University of Aarhus,Phase 3,2026-05-31,Liver Cirrhosis,"(None, 0)",,,0.0,169
NCT06541314,Fluzoparib Neoadjuvant Therapy for Ovarian Cancer,Qilu Hospital of Shandong University,Phase 2,2026-05-31,Ovarian Cancer,"(None, 0)",,,0.0,169
NCT06249919,"A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients","Neuracle Science Co., LTD.",Phase 2,2026-05-31,"Seneorineural Deafness, Sudden Sensorineural Hearing Loss","(None, 0)",,,0.0,169
NCT03697356,R-VRD Followed by Lenalidomide Maintenance in Patients With Waldenstrom's Macroglobulinemia,Kosin University Gospel Hospital,Phase 2,2026-05-31,Waldenström's Macroglobulinemia,"(None, 0)",,,0.0,169
NCT06427252,The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM,The First Affiliated Hospital with Nanjing Medical University,Phase 2,2026-05-31,"Gastric Cancer, Metastatic","(None, 0)",,,0.0,169
NCT04975919,Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia,M.D. Anderson Cancer Center,Phase 2,2026-05-31,"Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Biphenotypic Leukemia","(None, 0)",,,0.0,169
NCT05312879,Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease,Vertex Pharmaceuticals Incorporated,Phase 3,2026-05-31,Proteinuric Kidney Disease,"('VRTX', 100)",,,0.0,169
NCT05113537,Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer,Vadim S Koshkin,Phase 2,2026-05-31,"Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8","(None, 0)",,,0.0,169
NCT06496282,Lemborexant on Improving Sleep Quality Among Hospital Rotating Shift Workers,Phramongkutklao College of Medicine and Hospital,Phase 3,2026-05-31,Sleep,"(None, 0)",,,0.0,169
NCT05849779,Inhaled Sevoflurane for ARDS Prevention,"University Hospital, Clermont-Ferrand",Phase 3,2026-05-31,Acute Respiratory Distress Syndrome,"(None, 0)",,,0.0,169
NCT05642572,Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial),SWOG Cancer Research Network,Phase 2,2026-05-31,"Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8","(None, 0)",,,0.0,169
NCT06962865,A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC,"RemeGen Co., Ltd.",Phase 2,2026-05-31,Non-Small Cell Lung Cancer,"(None, 0)",,,0.0,169
NCT06598046,"A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC",Henan Cancer Hospital,Phase 2,2026-06-01,Metastatic Breast Cancer,"(None, 0)",,,0.0,170
NCT05864742,"Genetically Risk-Stratified Venetoclax, Ibrutinib, Rituximab (± Navitoclax) in Relapsed/Refractory Mantle Cell Lymphoma","Peter MacCallum Cancer Centre, Australia",Phase 2,2026-06-01,Mantle Cell Lymphoma Refractory,"(None, 0)",,,0.0,170
NCT05896566,A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast Cancer,ETOP IBCSG Partners Foundation,Phase 2,2026-06-01,Breast Cancer,"(None, 0)",,,0.0,170
NCT05595603,Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage,"Second Affiliated Hospital, School of Medicine, Zhejiang University",Phase 2,2026-06-01,Giant Cell Tumor of Bone,"(None, 0)",,,0.0,170
NCT06352008,To Evaluate the Efficacy and Safety of Anlotinib Hydrochloride Capsule in Postoperative Non-pCR Patients With Non-small Cell Lung Cancer,Tianjin Medical University Cancer Institute and Hospital,Phase 2,2026-06-01,Non-Small Cell Lung Cancer,"(None, 0)",,,0.0,170
NCT06454968,Orelabrutinib Combined With Obinutuzumab and Lenalidomide (OGL Regimen) as First-line Treatment for Marginal Zone Lymphoma.,Peking Union Medical College Hospital,Phase 2,2026-06-01,Marginal Zone Lymphoma,"(None, 0)",,,0.0,170
NCT06925516,A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC,Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University,Phase 2,2026-06-01,Intrahepatic Cholangiocarcinoma (Icc),"(None, 0)",,,0.0,170
NCT04493164,CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome,M.D. Anderson Cancer Center,Phase 2,2026-06-01,"Acute Myeloid Leukemia With Gene Mutations, Myelodysplastic Syndrome, Myeloproliferative Neoplasm","(None, 0)",,,0.0,170
NCT06079346,A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer,Oncotelic Inc.,Phase 3,2026-06-01,Pancreatic Ductal Adenocarcinoma,"(None, 0)",,,0.0,170
NCT04918173,Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery,Octapharma,Phase 3,2026-06-01,Congenital Antithrombin Deficiency,"(None, 0)",,,0.0,170
NCT03922542,Comparison of Standard vs. Accelerated Corneal Crosslinking,Price Vision Group,Phase 3,2026-06-01,"Keratoconus, Ectasia Corneal","(None, 0)",,,0.0,170
NCT04472767,Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma,"University of California, Irvine",Phase 2,2026-06-01,"Hepatocellular Carcinoma, HCC","(None, 0)",,,0.0,170
NCT06510699,Pharmacogenomics for Better Treatment of Fungal Infections in Cancer,The University of Queensland,Phase 2,2026-06-01,"Fungal Infection, Haematological Malignancy, Blood Cancer","(None, 0)",,,0.0,170
NCT06211634,"A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia",Hemab ApS,Phase 2,2026-06-01,Glanzmann Thrombasthenia,"(None, 0)",,,0.0,170
NCT06015659,ZN-c3 + Gemcitabine in Pancreatic Cancer,"Brandon Huffman, MD",Phase 2,2026-06-01,"Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma","(None, 0)",,,0.0,170
NCT06766825,Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults with Post-COVID-19 Condition (PCC),"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia",Phase 2,2026-06-01,"Post COVID-19 Condition, Long COVID Syndrome, Persistent COVID-19","(None, 0)",,,0.0,170
NCT06001762,TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer,Dana-Farber Cancer Institute,Phase 2,2026-06-01,"Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma","(None, 0)",,,0.0,170
NCT04335292,Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer with Osimertinib Third-line Rechallenge,Mark Vincent,Phase 2,2026-06-01,Non-Small Cell Lung Cancer,"(None, 0)",,,0.0,170
NCT05835505,Detoxification of the Liver In PSC (Dolphin),Brigham and Women's Hospital,Phase 2,2026-06-01,Primary Sclerosing Cholangitis,"(None, 0)",,,0.0,170
NCT03907475,"Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial",National Cancer Institute (NCI),Phase 2,2026-06-01,"Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm","(None, 0)",,,0.0,170
NCT04986579,Scalp Cooling in MBC,Dana-Farber Cancer Institute,Phase 2,2026-06-01,"Metastatic Breast Cancer, Chemotherapy-induced Alopecia","(None, 0)",,,0.0,170
NCT05345002,All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma,"Stephen Bagley, MD, MSCE",Phase 2,2026-06-01,"Glioma, IDH Mutation, Astrocytoma","(None, 0)",,,0.0,170
NCT05845723,Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome,Peking Union Medical College Hospital,Phase 2,2026-06-01,"Aneurysm, Behcet Syndrome, Vascular Type","(None, 0)",,,0.0,170
NCT06064929,A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old,"HI-Bio, A Biogen Company",Phase 2,2026-06-01,Lupus Nephritis,"('BIIB', 100)",,,0.0,170
NCT04888312,Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer Patients,Alligator Bioscience AB,Phase 2,2026-06-01,Metastatic Pancreatic Ductal Adenocarcinoma,"(None, 0)",,,0.0,170
NCT06113302,"A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes (MDS)",M.D. Anderson Cancer Center,Phase 2,2026-06-02,Myelodysplastic Syndromes,"(None, 0)",,,0.0,171
NCT05868265,A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract,Memorial Sloan Kettering Cancer Center,Phase 2,2026-06-02,Urothelial Carcinoma,"(None, 0)",,,0.0,171
NCT04550260,Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC,AstraZeneca,Phase 3,2026-06-02,Esophageal Squamous Cell Carcinoma,"('AZN', 100)",,,0.0,171
NCT05321875,Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial),Cristina Avendaño Solá,Phase 3,2026-06-02,"Cardiomyopathy, Dilated","(None, 0)",,,0.0,171
NCT06534411,"A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both",Novo Nordisk A/S,Phase 3,2026-06-02,"Diabetes Mellitus, Type 2","(None, 0)",,,0.0,171
NCT06973291,A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis,Takeda,Phase 3,2026-06-05,Plaque Psoriasis,"(None, 0)",,,0.0,174
NCT06704191,"In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial",Mayo Clinic,Phase 2,2026-06-06,"Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage I Bladder Cancer AJCC v8","(None, 0)",,,0.0,175
NCT06149559,A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis,UCB Biopharma SRL,Phase 3,2026-06-08,Generalized Myasthenia Gravis,"(None, 0)",,,0.0,177
NCT05957757,RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression,RenJi Hospital,Phase 2,2026-06-08,"Non-Muscle Invasive Bladder Cancer, HER2","(None, 0)",,,0.0,177
